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Executive Summary 
Background 
This thesis focuses on mechanisms of change and predictors of outcome in 
cognitive behavioural therapies for depressive and anxiety disorders.  
Cognitive behavioural therapies encompass a range of approaches. Therapies 
falling under the cognitive-behavioural umbrella have become one of the most 
dominant modalities of psychotherapy (Gaudiano, 2008) with a well-established 
evidence base for a range of mental health difficulties (Butler, Chapman, Forman, & 
Beck, 2006; Carpenter et al., 2018; Hofmann, Asnaani, Vonk, Sawyer, & Fang, 2012; 
Piet & Hougaard, 2011). Cognitive behavioural therapies are routinely recommended 
in national guidelines for the treatment of various mental health disorders, including 
the National Institute for Health and Care Excellence (NICE) guidelines in the UK. A 
recent commission on the future of psychological treatments research highlights that 
psychological treatments have a key role in the treatment of mental health difficulties, 
however there is a need to improve their efficacy as current treatments do not work for 
everyone (Holmes et al., 2018). Two recommendations for advancing psychological 
treatments include furthering research into their mechanisms and developing 
personalised models of treatment to understand who should be treated, “for what and 
with what” (Holmes et al., 2018). This research has the potential to support the 
refinement of treatments to directly target the processes responsible for change, 
improve precision in matching treatments to individuals, guide case formulation and 
identify the factors that contribute to differential treatment responses (Holmes et al., 
2018; Kazdin, 2007; Laurenceau, Hayes, & Feldman, 2007). This could enhance the 
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effectiveness and efficiency of existing treatments and support the development of 
novel treatments.  
There are several categories potential mechanisms of therapy might fall into 
including psychological, therapeutic, biological and neuropsychological, therapist 
related, demographic, disorder specific and social factors. Research into the process of 
psychotherapy and treatment mechanisms typically focuses on three questions: the 
course of change (individual trajectories over the course of therapy), moderators of 
change (for whom and under what conditions does change occur) and mediators of 
change (how and why change is occurring; Laurenceau et al., 2007). The systematic 
review chapter of this thesis focuses on psychological mediators of change in cognitive 
behavioural therapies for generalised anxiety disorder (GAD). The empirical study 
examines cognitive predictors of outcome in CBT for depression and anxiety disorders, 
which aimed to develop current understanding of treatment moderators. 
Systematic review 
The systematic review aimed to clarify the current position of research into 
mechanisms underlying therapeutic change in GAD. This was achieved through 
identifying research examining psychological mediators across cognitive behavioural 
psychotherapies for adults with GAD and providing a critical appraisal of this research, 
in line with the criteria recommended for mediation research (Kazdin, 2007).  
There are five main theoretical models which outline various psychological 
processes underlying the development and maintenance of GAD:  
• the avoidance model (Borkovec, 1994; Borkovec, Alcaine, & Behar, 2004) 
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• the intolerance of uncertainty model (Dugas, Letarte, Rheaume, Freeston, & 
Ladouceur, 1995; Freeston, Rheaume, Letarte, Dugas, & Ladouceur, 1994) 
• the metacognitive model (Wells, 1995) 
• the emotion dysregulation model (Mennin, Heimberg, Turk, & Fresco, 2002) 
• the acceptance-based model (Roemer & Orsillo, 2002) 
These form the basis for different psychological treatments for GAD and 
provide a starting point from which to understand potential mechanisms responsible for 
symptom change during therapy.  
In this review, three databases (PsychINFO, PubMed and Web of Science) were 
systematically searched to identify potentially relevant articles. Search terms were 
determined using three concepts: cognitive behavioural therapies, generalised anxiety 
disorder and mechanisms of change. Inclusion criteria were:  
Participants: 
1. met diagnostic criteria for GAD 
2. were aged 18 and over 
3. received a cognitive behavioural intervention 
Studies: 
4. had a primary focus on examining psychological mediators of change over the 
course of therapy 
5. were available in English 
6. were empirical research reports, rather than reviews, theoretical essays or 
commentaries 
7. employed a quantitative research design 
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Database searching identified 1,784 articles. Following removal of duplicates 
and screening titles, abstracts and full texts, 15 articles were included in the final 
review. Data extraction pulled out key details from each study and data assessment and 
critical appraisal assessed the extent to which studies met the criteria for mediation 
research (Kazdin, 2007): 
1. Statistical mediation: statistically demonstrating that the effect of treatment on 
the outcome is explained by the mediator 
2. Temporality: establishing the temporal relationship between mediator and 
outcome variables 
3. Experiment: experimentally manipulating the proposed mediator to rule out 
alternative explanations 
4. Specificity: demonstrating that associations between the intervention, proposed 
mediator and outcome are specific to that mediator 
5. Plausible processes: a plausible and coherent explanation accounting for the 
operation of the proposed mediator, typically in line with existing theory and 
evidence base 
6. Gradient: greater activation of the mediator should be associated with greater 
change in the outcome variable 
7. Consistency: associations between the intervention, proposed mediator and 
outcome should be consistent across studies, samples and conditions 
Gradient is included within statistical mediation analysis therefore was not 
reviewed as a separate criterion. Consistency was considered in the data synthesis rather 
than during assessment of individual studies. The use of valid and reliable measures 
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that are sensitive to change, adequate statistical power and fidelity to the intervention 
were also assessed.  
The included studies examined 17 potential mediators across seven treatments. 
Mediators examined were intolerance of uncertainty (IU), experiential avoidance, 
decentering, acceptance of internal experiences, engagement in valued action, 
mindfulness, metacognitive beliefs, cognitive and behavioural avoidance, interpersonal 
problems, safety behaviours, reassurance seeking, change in worry, change in somatic 
anxiety, perceived control, risk taking, repetitive negative thinking and flexibility of 
anxious symptoms. The different treatments were CBT, applied relaxation, acceptance-
based behaviour therapy, cognitive therapy, self-control desensitisation, worry 
exposure and metacognitive therapy.  
Of the 15 studies, 13 concluded that the hypothesised mediator was associated 
with change in outcomes following therapy. Proposed mediators that were not 
associated with change in outcomes were cognitive and behavioural avoidance, safety 
behaviours, reassurance-seeking and risk-taking. All other potential mediators were 
shown to be associated with change in outcomes. However, no studies met all the 
criteria required for assessing treatment mediators, which limited the conclusions that 
could be drawn about the operation of the proposed mediators, for example whether the 
proposed mediator was associated with change, its predictive value, or its specific 
mediational role over the course of treatment.  
IU, change in worry and change in somatic anxiety were examined in more than 
one study, therefore were the only mediators which could be assessed against the 
consistency criterion. These processes were shown to mediate change in outcomes, 
suggesting that these are important processes to consider and work to modify in therapy. 
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Other studies demonstrated that the proposed mediator was statistically associated with 
change in treatment outcomes, but it could not be concluded that they had a mediational 
role. This was primarily because the temporality criterion was not met; under these 
conditions, it is not known whether change in the proposed mediator led to change in 
symptoms or vice versa. Other methodological limitations included small sample sizes 
and that studies did not experimentally manipulate the proposed mediator, although, the 
external validity of studies able to manipulate the proposed mediator is thought to be 
limited.  
One of the biggest challenges in mediation research is demonstrating the 
temporal relationship between change in the mediator and change in outcomes and it 
will therefore be important for future research to address this.  
This review was limited by only including published studies and a lack of a 
second reviewer. However, it was able to summarise the current literature investigating 
mediators of outcome in cognitive behavioural therapies for GAD, provide a critical 
appraisal in line with requirements for mediational research, highlight clinical 
implications and make recommendations for future research.  
Empirical study 
The empirical study examined cognitive predictors, specifically attitudes and 
beliefs, of treatments outcomes in CBT.  
Research in the depression literature has demonstrated that lower levels of pre-
treatment dysfunctional attitudes and beliefs predict improved response to CBT. 
However, some studies have failed to replicate this association and others argue that 
there is a limited contributory role for cognitive processes in treatment outcomes. In 
anxiety disorders, the literature is more limited and results have mixed findings; some 
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studies have demonstrated that pre-treatment attitudes and beliefs significantly predict 
treatment outcomes, but others show no association.  
 This study was designed to examine attitudes and beliefs as predictors of 
treatment outcomes in CBT for depression and anxiety disorders in the pragmatic 
context of an Improving Access to Psychological Therapies (IAPT) service. It was 
hypothesised that: 
1. there will be a significant relationship between pre-treatment depression-related 
attitudes and beliefs and post-treatment outcomes, where greater levels of pre-
treatment maladaptive beliefs predict poorer outcomes in CBT. 
2. there will be a significant relationship between pre-treatment anxiety-related 
attitudes and beliefs and post-treatment outcomes, where greater levels of pre-
treatment maladaptive beliefs predict poorer outcomes in CBT. 
 
Data were collected from two IAPT services in London.  
• Service 1: data were collected in 2017-2018 and information about both 
depression and anxiety related attitudes and beliefs was gathered.  
• Service 2: data were collected in 2013-2014 and examined anxiety related 
attitudes and beliefs. 
Participants were those attending for high intensity CBT. The high intensity 
therapy pathway within IAPT services is for people with moderate/severe depression 
and/or anxiety difficulties. Data were collected from 141 individuals; 51 from Service 
1 and 90 from Service 2.  
The measures used to assess predictor and outcome variables were: 
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• Predictor variables 
o Dysfunctional Attitudes Scale – Short Form (DAS-SF). This is a nine-
item self-report questionnaire used to measure maladaptive beliefs 
associated with depression. 
o The Anxiety Attitudes and Beliefs Scale (AABS-18). This is an 18-item 
self-report scale designed to measure maladaptive beliefs related to 
anxiety disorders. 
• Outcomes 
o The Patient Health Questionnaire-9 (PHQ-9). This is a nine-item self-
report measure used to assess symptoms of depression.  
o The Generalised Anxiety Disorder-7 (GAD-7) questionnaire. This is a 
seven-item self-report measure used to assess anxiety symptoms.  
o Caseness. This term defines a clinical case of anxiety or depression. 
Someone is in caseness if their score is ≥10 on the PHQ-9 or ≥8 on the 
GAD-7. 
o Clinically significant improvement (CSI). Change from pre- to post-
treatment is deemed to be a clinically significant improvement if pre-
treatment scores are in caseness and post-treatment scores no longer 
meet this criterion. 
o Reliable improvement (RI). If an individual’s score changes by ≥6 on 
the PHQ-9 or ≥4 on the GAD-7, this is deemed to be a statistically 
reliable improvement, beyond that which could be due to measurement 
error. 
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o Reliable and clinically significant improvement (RCSI). A person is 
deemed to have made a RCSI when they meet the criteria for both CSI 
and RI. 
 PHQ-9 and GAD-7 data are collected routinely at each session in IAPT services. 
DAS-SF and AABS-18 data were introduced as routinely collected measures at high 
intensity therapy assessment appointments; both the DAS-SF and AABS-18 were 
collected at assessment in Service 1, but only AABS data were collected in Service 2.  
 Regression analyses were carried out to examine the predictive role of pre-
treatment attitudes and beliefs on treatment outcomes. Hierarchical linear regression 
analyses were completed where the outcome variable was continuous (PHQ-9 and 
GAD-7 scores) and logistic regression analyses were completed where the outcome 
variable was categorical (caseness, CSI, RI and RCSI). Pre-treatment symptom scores 
were entered at step 1 and DAS-SF or AABS-18 data were entered at step 2. This 
allowed examination of the predictive role of attitudes and beliefs on post-treatment 
symptoms over and above pre-treatment symptom levels. 
It was found that the hypotheses were not supported; pre-treatment attitudes and 
beliefs did not significantly predict post-treatment outcomes. Exploratory post-hoc 
analyses examining specific attitudes and beliefs revealed that body vigilance, anxiety-
based reasoning and catastrophising were correlated with post-treatment symptom 
severity. However, these attitudes and beliefs were not significant predictors of post-
treatment symptom severity, assessed in regression analyses.  
Results may indicate that pre-treatment anxiety related attitudes and beliefs do 
not have predictive role in understanding treatment outcomes; it might be that other 
cognitive or behavioural predictors have a more significant role. It is also possible that 
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attitudes and beliefs have a mediational, rather than predictive role in understanding 
treatment outcomes. However, there were some methodological limitations to the 
current study which may have influenced the findings. The size of the sample 
examining depression-related attitudes and beliefs was small and analyses were 
underpowered; it is therefore possible that a Type II error was made and an effect was 
missed. Participants in the current study had a range of diagnoses but only PHQ-9 and 
GAD-7 outcomes were collected. The outcome measures used may therefore not have 
captured the range of symptoms individuals presented with and not represented the 
change in symptoms individuals experienced during therapy. 
Examining predictors of treatment outcome is a complex area and various 
interacting factors are likely to contribute to treatment outcomes. Future research would 
benefit from addressing the methodological limitations encountered in this study and 
continuing to test processes from cognitive behavioural theories.  
Integration, Impact and Dissemination 
 During implementation of the empirical study some challenges were 
encountered with regards to data collection. This lead to the need to change the study 
design from examining cognitive mediators over the course of treatment to cognitive 
predictors. The empirical study therefore did not follow as clearly conceptually and 
methodologically from the systematic review as initially anticipated, but this allowed 
an examination of predictors of treatment outcome in line with personalised medicine 
approaches and key learning around carrying out research in routine clinical practice.  
 Following discussions with the service manager, clinical lead, admin manager, 
therapists and service user group various recruitment strategies were tested, which led 
to administrators giving questionnaires to clients who were attending the service for 
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their assessment. However, due to the increased workload for administrators, this was 
carried out for a limited period of one month. An effective solution would have been 
for me to identify clients attending for an assessment appointment and prepare a list for 
administration staff to identify clients and distribute questionnaires. An application was 
made to the Health Research Authority (HRA) Confidential Advisory Group (CAG) to 
request permission for this, however this was not processed in sufficient time. Future 
research would benefit from submitting this application at the time of ethical approval.  
 Following these challenges in recruitment, a research group of therapists in the 
service is being established to support the partnership between research and clinical 
practice. It is hoped that this will impact therapists on a personal development level as 
well as opportunities for research within the service. Attending service user group 
meetings was important and led to suggestions for future research and understanding of 
what is acceptable to clients around data collection.  
 This project led me to reflect on the role of clinical psychologists as researchers 
and clinicians and informed my understanding of research in the context of routine 
clinical practice. I hope this will inform my future career and allow me to understand 
and navigate the processes of clinically applied research effectively.  
 It is planned that this research will be disseminated through the publication of 
the systematic review, and possible publication of the results relating to anxiety related 
attitudes and beliefs in the empirical article, and presentation of the results to the service 
in which data collection took place. 
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Psychological Mediators in Cognitive Behavioural Therapies for Generalised 
Anxiety Disorder: A Systematic Review 
 
Abstract 
 Cognitive behavioural therapies have become increasingly prevalent in the 
treatment of mental health disorders and have strong empirical support for their 
efficacy. However, the mechanisms responsible for change in therapy are less well 
understood. Understanding mechanisms underlying therapeutic change is crucial in 
improving the efficacy and efficiency of treatments. This review aimed to examine the 
empirical literature on mediators of outcomes in cognitive behavioural therapies for 
generalised anxiety disorder (GAD) and provide a critical appraisal, in line with criteria 
recommended for mediation research.  
 Following a systematic search of three databases (PsychINFO, PubMed and 
Web of Science), 15 articles were identified to be included in the review. These studies 
examined 17 potential mediators relating to the intolerance of uncertainty, 
metacognitive, acceptance-based and avoidance models of GAD and the general 
cognitive behavioural model. Of the 15 studies, 13 concluded that the proposed 
mediator was associated with change in treatment outcomes. However, no studies met 
all the requirements for treatment mediation research and only intolerance of 
uncertainty, change in worry and change in somatic anxiety were examined in more 
than one study. These studies provided evidence that these processes have a mediational 
role in treatment outcomes, suggesting it is likely to be important to consider and work 
to modify these processes in treatments for GAD. Other hypothesised mediators were 
only examined in one study and the extent to which studies met the criteria for 
mediational research was variable, which limited the conclusions that could be drawn.  
19 
 
 Future research would benefit from refinement of research methodology in line 
with criteria required for mediational research, particularly establishing the temporal 
relationship between mediator and outcome variables, and building on the current 
literature by examining potential mediators currently shown to be associated with 
treatment outcomes. 
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Introduction 
Cognitive Behavioural Therapies. 
Research into psychological therapies has grown at an increasing rate over the 
past 50 years. Cognitive behavioural therapy (CBT) has become an increasingly 
popular approach (Gaudiano, 2008) with a rapidly growing evidence base for a number 
of different psychiatric disorders (Butler, Chapman, Forman, & Beck, 2006; Carpenter 
et al., 2018; S. G. Hofmann, Asnaani, Vonk, Sawyer, & Fang, 2012). 
Cognitive behavioural interventions hold the basic understanding that 
maladaptive cognitions and behaviours contribute to the development and maintenance 
of psychiatric disorders and psychological distress. CBT, therefore, aims to support 
patients in identifying, evaluating and modifying these maladaptive thinking patterns 
and behaviours in order to ameliorate symptoms (Hawton, Salkovskis, Kirk, & Clark, 
1989). A differing emphasis is placed on cognitive and behavioural strategies 
depending on factors such as the time point in therapy, diagnosis and client wishes. 
Recently, there has been an expansion of ‘third wave’ cognitive and behavioural 
therapies, which focus more on changing an individual’s relationship to their thoughts 
and emotions than on modifying their content, as in CBT (S. C. Hayes & Hofmann, 
2017; S. G. Hofmann, Sawyer, & Fang, 2010). Third wave approaches encompass 
interventions such as Acceptance and Commitment Therapy (ACT; Steven C Hayes, 
Luoma, Bond, Masuda, & Lillis, 2006) and Mindfulness-Based Cognitive Therapy 
(MBCT; Segal, Williams, & Teasdale, 2002).  
Cognitive behavioural therapies have an established evidence base for a broad 
range of mental health conditions, including depression (Piet & Hougaard, 2011; 
Zhang, Zhang, Zhang, Jin, & Zheng, 2018), anxiety disorders as a group (Carpenter et 
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al., 2018; S. G. Hofmann, Sawyer, Witt, & Oh, 2010; Normann, van Emmerik, & 
Morina, 2014) as well as individually, for example for generalised anxiety disorder 
(GAD; Cuijpers et al., 2014), panic disorder (Pompoli et al., 2016) and social anxiety 
disorder (Mayo-Wilson et al., 2014), obsessive compulsive disorder (OCD; Ost, 
Havnen, Hansen, & Kvale, 2015) and post-traumatic stress disorder (PTSD; Bisson, 
Roberts, Andrew, Cooper, & Lewis, 2013; Ehlers et al., 2010). However, although there 
is an established evidence base demonstrating the efficacy of cognitive and behavioural 
therapies, there remains a more limited understanding about how these therapies work 
and the extent to which theorised psychological processes influence symptom change 
over the course of therapy; the mechanisms underlying therapeutic change (Holmes et 
al., 2018). 
Research into possible mechanisms underlying therapeutic change has been 
increasing in depression and anxiety disorders, and there have been recent systematic 
reviews published outlining mechanisms of change in psychotherapies for depression 
(Lemmens, Müller, Arntz, & Huibers, 2016; Lorenzo-Luaces, German, & DeRubeis, 
2015; van der Velden et al., 2015) and anxiety disorders as a group (Smits, Julian, 
Rosenfield, & Powers, 2012). There have been relatively fewer reviews looking at 
specific anxiety disorders; there are systematic reviews examining mediators of change 
in CBT for panic disorder (Fentz, Arendt, O'Toole, Hoffart, & Hougaard, 2014) and 
OCD (Polman, Bouman, van Hout, de Jong, & den Boer, 2010) but none reviewing 
other anxiety disorders, including GAD. 
Generalised Anxiety Disorder. 
GAD is characterised by excessive anxiety and worry, among other symptoms 
such as difficulties concentrating, muscle tension and irritability (Diagnostic and 
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Statistical Manual of Mental Disorders - fifth edition (DSM-5; American Psychiatric 
Association, 2013). Worry has been defined as “an anxious apprehension for future, 
negative events (Barlow, 2002) that involves a predominance of negatively valenced 
verbal thought activity and minimal levels of imagery (Borkovec, Ray, & Stober, 1998, 
p. 562)” (Holaway, Rodebaugh, & Heimberg, 2006, p. 3). 
The global lifetime prevalence rate for GAD is assessed to be the highest out of 
the anxiety disorders and is estimated to be 6.2% (Remes, Brayne, Linde, & Lafortune, 
2016). In the UK, the most recent adult psychiatric morbidity survey estimated the one-
week prevalence rate of GAD to be 5.9% (McManus, Bebbington, Jenkins, & Brugha, 
2016), which is higher than other common mental health disorders including 
depression, phobias, obsessive compulsive disorder and panic disorder.  
The natural course of GAD tends to be chronic with a low spontaneous 
remission rate (Wittchen, 2002). There is a .38 probability of remission without 
treatment at 5 years after diagnosis, where remission is defined as occasional or no 
symptoms for eight consecutive weeks (Yonkers, Dyck, Warshaw, & Keller, 2000). 
Effective treatments for GAD are therefore key to recovery. However, even where 
people receive treatment, not everyone will see a remission in symptoms. A recent 
meta-analysis demonstrated that the mean remission rate in CBT for people with GAD 
is 51.4% and it was concluded that there is the potential and need to improve recovery 
rates (Springer, Levy, & Tolin, 2018).  
Theoretical models of GAD. 
There are a number of key theoretical models of GAD; the avoidance model 
(AM; Borkovec, 1994; Borkovec, Alcaine, & Behar, 2004), the intolerance of 
uncertainty model (IUM; Dugas, Letarte, Rheaume, Freeston, & Ladouceur, 1995; 
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Freeston, Rheaume, Letarte, Dugas, & Ladouceur, 1994), the metacognitive model 
(MCM; Wells, 1995), the emotion dysregulation model (EDM; Mennin, Heimberg, 
Turk, & Fresco, 2002), and the acceptance-based model (ABM; Roemer & Orsillo, 
2002).  
Each model emphasises varying psychological processes underlying the 
development and maintenance of GAD. The intolerance of uncertainty and 
metacognitive models are primarily cognitive models where maladaptive cognitions are 
hypothesised to be the primary mechanism contributing to the development and 
maintenance of GAD. The acceptance-based and emotion dysregulation models are 
emotional or experiential models, where the key contributing mechanisms are 
maladaptive emotions and behaviours. The avoidance model is an integrated model 
which places equal emphasis on cognitive, emotional and behavioural elements as 
mechanisms responsible for the development and maintenance of GAD, alongside other 
factors including interpersonal relationships and attachment style. The different 
theorised processes underlying each of these models are outlined in Table 1; however 
common to all the models is an emphasis on a key role for avoidance of internal 
experiences, whether this is vivid images and somatic activation (AM), uncertainty 
(IUM), worrying about worry (MCM), emotions (EDM) or is a type of experiential 
avoidance of internal experiences (ABM; Behar, DiMarco, Hekler, Mohlman, & 
Staples, 2009). 
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Table 1 
Summary of the key theoretical components of each model of GAD (Behar et al., 2009) 
Model of GAD Theoretical components 
Avoidance model Cognitive avoidance 
Positive worry beliefs 
Ineffective problem-solving/emotional 
processing 
Interpersonal issues 
Attachment style 
Previous trauma 
Intolerance of uncertainty model Intolerance of uncertainty 
Negative problem orientation 
Cognitive avoidance 
Beliefs about worry 
Metacognitive model Positive beliefs about worry 
Type 1 Worry 
Negative beliefs about worry 
Type 2 Worry 
Ineffective coping 
Emotion dysregulation model Emotional hyperarousal 
Poor understanding of emotions 
Negative cognitive reactions to emotions 
Maladaptive emotion management and 
regulation 
Acceptance-Based model Internal experiences 
Problematic relationship with internal 
experiences 
Experiential avoidance 
Behavioural restriction 
 
These models have a theoretical and empirical basis for understanding the 
development and maintenance of GAD, have formed the basis of different 
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psychotherapeutic interventions for GAD (Behar et al., 2009) and point towards various 
possible psychological mechanisms that might contribute to therapeutic change. 
Interventions for GAD. 
 CBT has the strongest evidence base for the psychotherapeutic treatment of 
GAD (Cuijpers et al., 2014; Hunot, Churchill, Teixeira, & de Lima, 2007), alongside 
applied relaxation (AR; Arntz, 2003; Ost & Breitholtz, 2000), and both are 
recommended in the National Institute for Health and Care Excellence (NICE) 
guidelines for the treatment of GAD (NICE, 2011). CBT interventions typically focus 
on the intolerance of uncertainty (Dugas & Ladouceur, 2000) and metacognitive (Wells 
& King, 2006; Wells et al., 2010) models, both of which have been shown to be 
effective for the treatment of GAD (van der Heiden, Muris, & van der Molen, 2012).  
 However, as previously outlined, there remains the need to enhance the efficacy 
of these interventions and improve recovery rates (Behar et al., 2009; Springer et al., 
2018). This has led to the development of new therapies which refine and expand on 
existing models of GAD. Recently, acceptance-based behaviour therapy (ABBT) has 
been developed, based on the acceptance-based model (Roemer & Orsillo, 2002), 
which has emerging evidence for the efficacy of treating GAD (Hayes-Skelton, 
Roemer, & Orsillo, 2013). 
Mechanisms of psychological treatments. 
Mechanisms are defined as “the processes or events that are responsible for the 
change; the reasons why change occurred or how change came about” (Kazdin, 2007, 
p. 3). Holmes et al. (2018) explain that a mechanism is “an explanatory construct and 
not simply an intervening variable that explains the statistical association between an 
intervention and an outcome” (p. 241). Identifying mechanisms underlying therapeutic 
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change is crucial in understanding the links between psychological treatments and the 
diverse outcomes observed, understanding the specific therapeutic components 
required for change, refining treatment to directly target the mechanisms, developing 
new treatments with enhanced efficiency and efficacy, and in generalising treatment 
effects from research to clinical practice (Holmes et al., 2018; Kazdin, 2007; 
Laurenceau, Hayes, & Feldman, 2007). Identifying key mechanisms of psychological 
treatments may develop our understanding of individual factors contributing to 
differential treatment responses, thus improving personalised treatments, which has the 
potential to improve intervention efficacy.  
 Mechanisms underlying psychotherapeutic change often overlap with processes 
that underlie the development and maintenance of psychopathology (Holmes et al., 
2018) and recent recommendations suggest identifying biopsychosocial factors that 
could explain change throughout treatment (Holmes et al., 2018; Kozak & Cuthbert, 
2016). Potential mechanisms of therapeutic change may fall into the following 
categories (Schneider, Arch, & Wolitzky-Taylor, 2015): 
• Psychological factors. This includes factors such as thoughts (content and 
process), attitudes, beliefs and schemas, behaviours, coping strategies, 
dispositional characteristics such as intolerance of uncertainty, attachment style, 
attentional control, memory, executive functioning, and information processing. 
• Therapeutic factors, such as the therapeutic alliance and trust, client and 
therapist beliefs and expectations about therapy, motivation to engage in 
therapy, resistance and ambivalence, participation in therapy, early changes and 
sudden gains in treatment, therapy specific behaviours, treatment preferences, 
and the language used in therapy (e.g. change talk). 
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• Biological and neuropsychological factors such as genetics, neural circuits and 
physiology. 
• Therapist factors such as therapist experience and competence and perceived 
therapist empathy. 
• Client demographic factors such as age, gender, ethnicity and level of 
education. 
• Disorder specific factors such as symptom severity, comorbid disorders and 
length of time a person has had the disorder. 
• Social factors such as level of social support. 
 Mechanisms underlying the development and maintenance of psychopathology 
have been described as varying from predominantly distal (for example the influence 
of adverse events in childhood that impact a person in adulthood) to predominantly 
proximal (for example attentional biases in anxiety disorders) and predominantly fixed 
(for example genes) to predominantly malleable (for example cognitive biases); 
psychological treatments typically target proximal, malleable mechanisms (Holmes et 
al., 2018). 
Establishing mechanisms of change. 
To examine mechanisms of change in psychological treatments, the 
identification of mediators is a crucial step (Kazdin, 2007). Mediators represent 
potential mechanisms and are defined as “a variable that statistically explains why and 
in what way a treatment has an effect on outcome” (Lemmens et al., 2017, p. 96) and 
are typically the constructs that an intervention is designed to change (Laurenceau et 
al., 2007). A mediator does not necessarily explain the exact process by which change 
occurred; mediators might indicate possible mechanisms but are not necessarily 
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mechanisms of change (Kazdin, 2007). In contrast, a moderator is defined as a 
“characteristic that influences the direction or magnitude of the relation between the 
intervention and outcome” (Kazdin, 2007, p. 3). Moderators indicate for whom and 
under what conditions an intervention works and are factors that would be present prior 
to treatment (Laurenceau et al., 2007). 
 There are a number of criteria required to establish a mediator. Previously, 
identifying mediator variables referred only to statistical mediation: statistically 
demonstrating that the effect of treatment on the outcome is explained by the mediator 
(Lemmens et al., 2016). This predominantly included methods proposed by Baron and 
Kenny (1986) and, more recently, the MacArthur group (Kraemer, Stice, Kazdin, 
Offord, & Kupfer, 2001; Kraemer, Wilson, Fairburn, & Agras, 2002). Statistical 
mediation should show that the therapeutic intervention is associated with change in 
the proposed mediator and that change in the proposed mediator is associated with 
change in the outcome (Holmes et al., 2018; Kazdin, 2007; Lemmens et al., 2016). 
However, although statistical mediation is important, it is now considered to be 
insufficient to draw clear conclusions about whether a hypothesised mediator explains 
change in outcomes (Johansson & Høglend, 2007; Lemmens et al., 2016). In addition 
to statistical mediation, demonstrating the direction of causality is considered to be 
crucial (Lemmens et al., 2016) and, in order to do this, Kazdin (2007, 2009) suggests 
six requirements: 
1. Temporality: establish a temporal relationship between the proposed mediator 
and outcome. This involves assessment of both the mediator and outcome 
variables on multiple occasions during treatment, ideally in every treatment 
session (Holmes et al., 2018). It should be established that treatment causes the 
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mediator variable to change, which in turn leads to change in the outcome 
variable, and not the other way around. 
2. Experiment: experimental manipulation of the proposed mediator can help to 
rule out alternative explanations for associations between the proposed mediator 
and outcome. 
3. Specificity: demonstrating that associations between the intervention, proposed 
mediator and outcome are specific to that mediator, rather than multiple 
mediators accounting for changes in outcome.  
4. Plausible processes: there should be a plausible and coherent explanation to 
account for how the proposed mediator operates, which should typically be in 
line with theory and the existing evidence base. 
5. Gradient: demonstrating that greater activation of the mediator is associated 
with greater change in the outcome variable or that a dose-response relationship 
between the mediator and outcome variables is present. 
6. Consistency: demonstrating that associations between the intervention, 
proposed mediator and outcome are consistent across studies, samples and 
conditions. 
Examination of the role of proposed mediators should begin with statistical tests 
of mediation, after which each criterion can be reviewed to establish the extent to which 
each is met (Lemmens et al., 2016). Considering these criteria strengthen the evidence 
as, if fulfilled, this increases confidence in conclusions about the role of a proposed 
mediator (Kazdin, 2007). However, Kazdin and Nock (2003) highlight that not all 
criteria should be given equal weighting; they suggest that statistical association, 
temporality, experiment and specificity are the most important, with plausible 
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processes, consistency and gradient being used to further enhance the evidence. In 
addition, measures used to assess potential mediators should be reliable, valid and 
sensitive to change and mediators should be assessed in the context of adequately 
powered clinical trials (Holmes et al., 2018). 
Aims of the current review. 
Given the chronic course and low rates of spontaneous remission for GAD, the 
development and refinement of effective treatments is critical. Although there are 
effective treatments for GAD, there remains a limited understanding about the 
mechanisms underlying therapeutic change and the capacity to improve treatment 
recovery rates (Holmes et al., 2018; Smits et al., 2012; Springer et al., 2018). 
Understanding the mechanisms of therapeutic change has the potential to develop our 
understanding of how treatments for GAD work and therefore allow the development 
and refinement of treatments to improve efficacy. A recent commission by Holmes et 
al. (2018) makes ten suggestions for advancements in psychological treatment research 
which highlights the importance of furthering understanding of the mechanisms 
underlying psychological treatments. 
 This review aimed to focus on psychological mechanisms of change in 
cognitive behavioural therapies for GAD. There have been recent reviews on 
mechanisms of therapeutic change in other mental health disorders including 
depression (Lemmens et al., 2016; Lorenzo-Luaces et al., 2015), anxiety disorders as a 
group (Arch & Craske, 2008; Powers, de Kleine, & Smits, 2017; Smits et al., 2012), 
personality disorders (Forster, Berthollier, & Rawlinson, 2014), panic disorder (Fentz 
et al., 2014) and OCD (Polman et al., 2010), however none that have specifically 
focused on generalised anxiety disorder. This review aimed to clarify the current 
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position of research into mechanisms underlying therapeutic change in GAD through 
understanding which psychological mediators have been identified across cognitive 
behavioural psychotherapies for adults with GAD and providing a critical appraisal of 
this research.  
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Method 
This review was designed and conducted with reference to the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines 
(Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 2009). 
Eligibility Criteria. 
The current review sought to identify empirical studies that examined 
psychological mediators of change over the course of cognitive behavioural therapies 
for GAD. The literature search included all published articles up to January 2018. The 
inclusion criteria were: (a) participants met diagnostic criteria for generalised anxiety 
disorder, (b) participants were aged 18 and over, (c) participants received a cognitive 
behavioural intervention (d) studies had a primary focus on examining psychological 
mediators of change over the course of therapy, (e) studies were available in English, 
(f) studies were empirical research reports, rather than reviews, theoretical essays or 
commentaries and (g) studies employed a quantitative research design.  
Search strategy. 
Three databases (PsychINFO, PubMed and Web of Science) were 
systematically searched to identify potentially relevant articles. Search terms were 
determined using three concepts: cognitive behavioural therapies, generalised anxiety 
disorder and mechanisms of change. Within each concept, the Boolean operator ‘OR’ 
was used and the Boolean operator ‘AND’ was used to combine concepts. The search 
terms are outlined in Table 2.  
Following the initial database search, records were exported to Endnote and 
duplicates removed. After this, titles, abstracts and then full texts were screened to 
assess for eligibility. When screening full texts, reasons for exclusion were noted. 
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Reference lists of selected articles were subsequently searched to identify any other 
relevant articles, of which the abstracts then full texts were screened for eligibility.  
Table 2 
Search terms used to identify articles 
Concept Search Term 
Cognitive Behavioural 
Therapies 
 
 
 
 
 
Psychotherap* OR Psychological treatment OR 
Psychological intervention OR psychological therap* 
OR Cognitive behavio*ral therapy OR CBT OR 
cognitive therap* OR cognitive psychotherap* OR 
behaviour* therapy OR behavior* therapy OR 
metacognitive therap* OR acceptance and 
commitment therapy OR ACT OR mindfulness-
based cognitive therapy OR MBCT 
Generalised Anxiety 
Disorder 
Generalised anxiety disorder OR Generalized anxiety 
disorder OR GAD  
Mechanisms of change mechanisms OR mechanisms of change OR 
mediation OR mediator OR mediating effects OR 
process OR processes OR process research OR 
change OR processes of therapy OR predictor 
 
Data extraction. 
The following information was extracted from each study: (a) study design, (b) 
study location, (c) participant characteristics including age, gender and diagnosis, (d) 
hypothesised mediators, (e) intervention, (f) measures used to assess mediators and 
outcomes, (g) frequency of measurement, and (h) the key findings.   
Data assessment and critical appraisal. 
Given the recommendations for criteria required to assess potential mediator 
variables, articles were assessed to establish whether they met the requirements for 
mediation research. This approach has been used in other systematic reviews examining 
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mechanisms of change in therapy (Lemmens et al., 2016; Smits et al., 2012) and 
allowed review-specific rather than generic data appraisal. The criteria examined were: 
(a) inclusion of statistical mediation analysis, (b) assessment of temporality (defined by 
three or more assessments in the treatment phase (Lemmens et al., 2016), (c) 
experimental manipulation of the proposed mediator to rule out alternative 
explanations, (d) assessment of specificity through testing multiple mediators or 
multiple treatments where potential mediators both have and do not have a theoretical 
association with the treatment, (e) the use of valid and reliable measures that are 
sensitive to change, (f) adequate statistical power, and (g) a plausible and coherent 
explanation of how the proposed mediator operates. Fidelity to the intervention was 
also examined to review whether all participants received the same intervention and 
whether the intervention delivered was in line with the treatment protocol. 
Gradient is included within statistical mediation analysis therefore was not 
reviewed as a separate criterion. Given that the criterion of consistency requires 
reviewing mediators across studies, it was not appropriate to include this in an 
assessment of individual studies, however this is considered in the data synthesis. 
Each study was rated with respect to whether they met (+) or did not meet (-) 
each of these criteria, and this information was compared across the studies and 
summarised.  
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Results 
Database searching identified 1,784 articles. Two additional articles were 
identified though other sources. Removal of duplicates left a total of 1,175 unique 
articles. During screening titles and abstracts, 1,153 studies were deemed not to meet 
inclusion criteria and were therefore excluded. The full text of 27 articles were assessed 
for eligibility and reference lists were screened to check for other relevant articles. One 
new article was found, and 15 were included in the final review. Figure 1 highlights the 
article selection process.  
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Records identified through database 
searching 
(n = 1,784) 
PsycINFO (n = 1,151) 
Web of Science (n = 506) 
PubMed (n = 127) 
Additional records identified 
through other sources 
(n = 2) 
Records after duplicates removed 
(n = 1,175) 
Titles screened 
(n = 1,175) 
Records excluded 
(n = 919) 
Records excluded 
(n = 229) 
Reference lists inspected 
(n = 27) 
Full-text articles assessed 
for eligibility 
(n = 27) 
Full-text articles excluded 
(n = 13) 
Reasons 
Study not specific to GAD 
(n=6); did not look at 
psychological mediators 
(n=1); examined 
moderators (n=2); 
mediator not measured in 
relation to treatment or 
treatment outcome (n=2); 
paper did not include 
results relating to mediator 
analyses (n=1); abstract 
(n=1) 
Abstracts screened 
(n = 256) 
Studies included in the 
review 
(n = 15) 
Additional relevant articles 
identified 
(n = 1) 
Figure 1. PRISMA flow diagram outlining the study selection process 
37 
 
Study characteristics. 
Table 3 provides an overview of the characteristics and results of studies 
included in this review. All the studies were carried out in the Western world, the 
majority in the USA (47% vs. 27% in Canada, 20% in Australia and 6% in Europe) and 
60% were published in the last 5 years (2013 – 2018). All but one of the studies took 
place in outpatient clinics, the remaining study took place online (Lorian, Titov, & 
Grisham, 2012). Sample size ranged from n = 4 – 131, with a mean of n = 58 (standard 
deviation (SD) = 29.90). Participants were adults and the mean age was 36.43 years 
(SD = 4.34). The majority of participants were female (mean = 66.39%, SD = 5.98). 
One study did not report demographic data and one reported data for age but not gender. 
CBT was the most frequently researched intervention, examined in eight of the 
15 studies; this encompassed individual face-to-face CBT (n = 6; Bomyea et al., 2015; 
Donegan & Dugas, 2012; Dugas, Francis, & Bouchard, 2009; Dugas & Ladouceur, 
2000; Gallagher, Naragon-Gainey, & Brown, 2014; Newman & Fisher, 2013), internet 
CBT (n = 1; Lorian et al., 2012) and group CBT (n = 1; Torbit & Laposa, 2016). Applied 
Relaxation (AR) was the next most frequently studied intervention, included in six 
studies (Beesdo-Baum et al., 2012; Donegan & Dugas, 2012; Dugas et al., 2009; Eustis, 
Hayes-Skelton, Roemer, & Orsillo, 2016; Hayes-Skelton, Calloway, Roemer, & 
Orsillo, 2015; Millstein, Orsillo, Hayes-Skelton, & Roemer, 2015), followed by 
Acceptance-Based Behaviour Therapy (ABBT), examined in four studies (Eustis et al., 
2016; Hayes-Skelton et al., 2015; S. A. Hayes, Orsillo, & Roemer, 2010; Millstein et 
al., 2015). Other interventions included group metacognitive therapy (MCT, n = 2; 
McEvoy & Erceg-Hurn, 2016; McEvoy, Erceg-Hurn, Anderson, Campbell, & Nathan, 
2015), cognitive therapy (CT, n = 1; Newman & Fisher, 2013), self-control 
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desensitisation (SCD, n = 1; Newman & Fisher, 2013) and worry exposure (n = 1; 
Beesdo-Baum et al., 2012). Eight studies examined more than one therapeutic method 
(Beesdo-Baum et al., 2012; Donegan & Dugas, 2012; Dugas et al., 2009; Eustis et al., 
2016; Hayes-Skelton et al., 2015; Lorian et al., 2012; Millstein et al., 2015; Newman 
& Fisher, 2013). 
All studies used clinician administered interviews to assess diagnosis. All 
studies included self-report measures to measure the mediator and outcome variables 
and eight studies used both self-report and clinician-rated measures of GAD as an 
outcome measure. The most commonly used self-report measure of GAD symptom 
severity was the Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & 
Borkovec, 1990), which was used in 12 of the 15 studies. Clinician-rated measures were 
the Hamilton Anxiety Rating Scale (HARS; Hamilton, 1959), which was implemented 
in two studies, and different versions of the Anxiety Disorders Interview Schedule 
(ADIS), which was used in nine studies, two of which used the revised version based 
on DSM-III criteria (ADIS-R; Di Nardo & Barlow, 1988), four of which used the ADIS 
for DSM-IV (ADIS-IV; Brown, DiNardo, & Barlow, 1994), and three of which used 
the ADIS for DSM-IV - lifetime version (ADIS-IV-L; DiNardo, Brown, & Barlow, 
1994).  
The studies examined 17 potential mediators. These mediators related to 
theorised models of GAD including intolerance of uncertainty (intolerance of 
uncertainty model) which was examined in four studies (Bomyea et al., 2015; Dugas & 
Ladouceur, 2000; McEvoy & Erceg-Hurn, 2016; Torbit & Laposa, 2016), processes 
associated with the acceptance-based model including experiential avoidance (n = 1; 
Eustis et al., 2016), decentering (n = 1; Hayes-Skelton et al., 2015), acceptance of 
39 
 
internal experiences and engagement in valued action (n = 1; S. A. Hayes et al., 2010), 
and mindfulness (n = 1; Millstein et al., 2015). Metacognitive beliefs (metacognitive 
model) were examined in one study (McEvoy et al., 2015), and processes related to the 
avoidance model were examined in two studies, including cognitive and behavioural 
avoidance (n = 1; Beesdo-Baum et al., 2012) and interpersonal problems (n = 1; 
Millstein et al., 2015). Other potential mediators were more general cognitive and 
behavioural processes related to worry and anxiety, including safety behaviours (n = 1; 
Beesdo-Baum et al., 2012), reassurance seeking (n = 1; Beesdo-Baum et al., 2012), 
change in worry and change in somatic anxiety (n = 2; Donegan & Dugas, 2012; Dugas 
et al., 2009), perceived control (n = 1; Gallagher et al., 2014), risk taking (n = 1; Lorian 
et al., 2012), repetitive negative thinking (n = 1; McEvoy et al., 2015) and flexibility of 
symptoms of anxiety (n = 1; Newman & Fisher, 2013). Five studies examined more 
than one potential mediator (Beesdo-Baum et al., 2012; Donegan & Dugas, 2012; 
Dugas et al., 2009; S. A. Hayes et al., 2010; McEvoy et al., 2015). 
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Table 3 
Data extraction: study characteristics and results 
Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Beesdo‐Baum, 
Jenjahn,  
Höfler, 
Lueken, 
Becker & 
Hoyer  
2012 
Germany 
 
Randomised 
controlled 
trial (RCT) 
 
Worry 
exposure 
vs. applied 
relaxation 
vs. waitlist 
control  
 
n = 56 
45.5 years (13.3) 
71.3% female  
GAD (DSM-IV) 
Cognitive and 
behavioural 
avoidance 
 
Safety 
behaviours 
 
Reassurance 
seeking 
 
 
 
 
Worry exposure  
(n = 29) 
 
Applied 
Relaxation (AR; 
n = 27) 
Outcome 
Clinician rated 
Hamilton Anxiety Rating Scale 
(HARS) 
Pre- and post-treatment 
Self-report 
Penn State Worry Questionnaire 
(PSWQ) 
Pre- and post-treatment, 6 and 12-
month follow up 
Mediator 
Behavioural symptoms (9-point 
Likert scale) 
Weekly 
 
At pre-treatment, the hypothesised 
mediator variables were unrelated 
to treatment outcomes. 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Diagnosis 
Clinician administered 
DSM-IV Munich Composite 
International Diagnostic Interview 
Bomyea, 
Ramsawh, 
Ball, Taylor, 
Paulus, Lang 
& Stein 
2015 
USA 
Cohort 
study  
 
Cognitive 
Behavioural 
Therapy 
n = 28 
34.4 years (10.8) 
71.4% female 
GAD (DSM-IV) 
Intolerance of 
uncertainty 
(IU) 
 
Cognitive 
Behavioural 
Therapy (CBT) 
Outcome 
Self-report 
Abbreviated PSWQ 
Pre-treatment and bi-weekly during 
treatment 
Mediator  
Intolerance of Uncertainty Scale 
(IUS). Pre-treatment and bi-weekly 
during treatment 
Diagnosis 
Clinician administered 
Mini-International 
Neuropsychiatric Interview (MINI) 
Change in IU mediated change in 
worry. Reductions in IU 
accounted for 59% of the 
reductions in worry over 
treatment. 
 
Change in worry did not mediate 
change in IU. Change in worry 
accounted for less than 1% of the 
reduction in IU over treatment. 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Donegan & 
Dugas 
2012 
Canada 
RCT 
 
CBT vs. 
AR 
n = 57 
38.4 years (12.38) 
66% female 
GAD (DSM-IV) 
 
 
Change in 
worry 
 
Change in 
somatic 
anxiety 
 
CBT (n = 31)  
 
AR (n = 26) 
Outcome / Mediator 
Self-report 
Self-monitoring booklet: % of each 
day spent worrying and 
experiencing somatic anxiety 
Daily 
Symptom severity  
Self-report 
PSWQ 
Worry and Anxiety Questionnaire 
(WAQ) 
The Beck Depression Inventory-II 
(BDI-II) 
Pre-treatment 
 
Change in worry accounted for 
49.45% of the change in somatic 
anxiety in CBT and 25.87% of the 
change in somatic anxiety in AR.  
 
Change in somatic anxiety 
accounted for 57.76% of the 
change in worry in CBT and 
48.57% of the change in worry in 
AR. 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Diagnosis  
Clinician-administered 
MINI, Version 4.4 
Anxiety Disorders Interview 
Schedule (ADIS) for DSM–IV 
Dugas, Francis 
& Bouchard 
2009 
Canada 
RCT 
 
CBT vs. 
AR 
n = 20 
36.9 years (12.3) 
70% female 
GAD (DSM-IV) 
Change in 
worry 
 
Change in 
somatic 
anxiety 
 
CBT (n = 10) 
 
AR (n = 10) 
Outcome / Mediator 
Self-report 
Self-monitoring booklet: % of each 
day spent worrying, experiencing 
somatic anxiety and feeling 
depressed 
Daily 
Symptom severity 
Self-report 
PSWQ 
WAQ – Somatic subscale 
Pre- and post-treatment 
Change in worry predicted change 
in somatic anxiety. Change in 
somatic anxiety predicted change 
in worry. 
 
80% of participants receiving 
CBT and 70% receiving AR 
showed a bidirectional 
relationship between worry and 
somatic anxiety.  
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Diagnosis 
Clinician-administered 
MINI 
ADIS for DSM–IV 
Dugas & 
Ladouceur  
2000 
Canada 
Multiple 
baseline 
single case 
design 
n = 4 
28.5 years (13.1) 
50% female 
GAD (DSM-IV) 
IU 
 
 
CBT Outcome 
Self-report 
Self-monitoring booklet: time spent 
worrying on a daily basis (0-100) 
Daily 
Mediator 
IUS 
Pre- and post-treatment, 6-month 
and 12-month follow-up 
Self-monitoring booklet: one item 
from the IUS  
Daily 
Changes in IU were related to 
treatment outcomes.  
 
Changes in IU preceded changes 
in time spent worrying for 3 of the 
4 participants. 
 
Changes in time spent worrying 
never preceded changes in IU. 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Symptom severity 
Self-report 
PSWQ 
Generalised Anxiety Disorder 
Questionnaire (GAD-Q) 
Beck Anxiety Inventory (BAI) 
BDI-II 
Pre- and post-treatment, 6-month 
and 12-month follow-up 
Diagnosis 
Clinician-administered 
ADIS-Revised 
Eustis, 
Hayes-
Skelton, 
RCT 
 
ABBT vs. 
AR 
n = 64 
65.6% female 
34.4 years (12.14) 
GAD (DSM-IV) 
Experiential 
avoidance 
 
 
Acceptance 
based behaviour 
therapy (ABBT; 
n = 40) 
Outcome 
Self-report 
PSWQ 
Quality of Life Inventory (QoLI) 
Greater change in experiential 
avoidance across treatment 
significantly predicted change in 
46 
 
Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Roemer & 
Orsillo 
2016 
USA 
  
AR (n = 41) 
 
Pre-treatment and post-treatment 
Mediator 
Self-report 
Acceptance and Action 
Questionnaire (AAQ) 
Experiences Questionnaire (EQ) 
Decentering Subscale 
Per-treatment, mid-treatment (week 
4, week 8, week 12), post-treatment 
Diagnosis 
Clinician-administered 
ADIS for DSM-IV-TR-Lifetime 
version 
 
worry and quality of life across 
both ABBT and AR. 
 
Experiential avoidance was 
related to changes in outcomes 
above and beyond decentering 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Gallagher, 
Naragon-
Gainey, 
Brown 
2014 
USA 
Controlled 
trial 
 
People who 
initiated 
CBT vs. 
people who 
declined 
treatment 
n = 131 
Demographics for 
GAD clients not 
reported 
GAD (DSM-IV) 
Perceived 
control 
 
 
CBT Outcome 
Clinician-rated 
Three ADIS for DSM-IV 
dimensional rating measures 
Mediator 
Self-report 
Revised Anxiety Control 
Questionnaire – emotion control, 
threat control and stress control 
subscales 
Diagnosis  
Clinician-administered 
ADIS for DSM-IV-TR-Lifetime 
version 
All measures: pre-treatment, 12-
month follow-up, 24-month follow-
up 
Changes in perceived control 
were significant predictors of 
changes in symptoms of GAD. 
 
Individuals initiating CBT 
reported increases in perceived 
control. Changes in perceived 
control mediated change in 
symptoms of GAD.  
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Hayes, Orsillo 
& Roemer 
2010 
USA 
 
 
Data used 
from two 
studies: a 
wait-list 
control trial 
and open 
trial 
 
Data were 
only 
included 
from 
participants 
who 
received 
ABBT 
n = 43 
67.4% female 
33.7 years (11.97) 
GAD (DSM-IV) 
 
 
 
Acceptance of 
internal 
experiences  
 
Engagement in 
valued action 
 
ABBT 
 
 
Outcome 
Clinician-rated 
Clinicians’ Severity Rating for 
GAD - ADIS DSM-IV-TR-
Lifetime version 
Pre and post-treatment 
Self-report 
PSWQ 
Depression Anxiety and Stress 
Scale (DASS) 
QoLI 
Pre and post-treatment 
Weekly Assessment: % of time 
spent engaged in certain therapy-
relevant activities over the 
preceding week (0 – 100) 
Responder status: change in 
acceptance and change in valued 
action significantly predicted 
post-treatment responder status.  
 
Quality of life: change in 
acceptance, but not change in 
valued action, significantly 
predicted post-treatment quality 
of life while controlling for pre-
treatment quality of life scores.  
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
 
Weekly, prior to each therapy 
session 
Treatment responders: 
demonstrated a 20% or greater 
reduction from pre- to post-
treatment on at least three of four 
anxiety measure (Clinicians’ 
Severity Rating, PSWQ, the DASS 
– Anxiety and Stress subscales) 
Mediator 
AAQ 
Valued Living Questionnaire 
(VLQ) 
Pre- and post-treatment 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Diagnosis  
Clinician-administered 
ADIS for DSM-IV-TR-Lifetime 
version 
Hayes-
Skelton, 
Calloway, 
Roemer & 
Orsillo 
2015 
USA 
RCT 
 
ABBT vs. 
AR 
n = 64 
65.6% female 
34.4 years (12.14)  
GAD (DSM-IV) 
 
 
Decentering  
 
 
 
ABBT (n = 31)  
 
AR (n = 33) 
Outcome  
Self-report 
PSWQ 
Pre- and post-treatment 
Mediator 
Self-report 
EQ-Decentering subscale 
DASS 21-item version 
Pre-treatment, sessions 4, 8 and 12, 
and post-treatment 
 
 
Increases in decentering were 
associated with decreases in 
worry symptoms and anxiety. 
Changes in decentering preceded 
changes in symptoms in both 
ABBT and AR 
 
General anxiety symptoms were 
not a significant predictor of 
change in decentering.  
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Diagnosis 
Clinician-administered 
ADIS for DSM-IV 
Lorian, Titov 
& Grisham 
2012 
Australia 
 
RCT 
 
CBT vs. 
waitlist 
control 
n = 44 
73% female 
44.2 years (12.9) 
GAD (DSM-IV) 
 
 
 
Risk-taking 
(social and 
recreational) 
 
 
Internet CBT  
(n = 24) 
 
Control (n = 20) 
Outcome 
Self-report 
PSWQ 
Generalized Anxiety Disorder 7-
Item Scale (GAD-7) 
Patient Health Questionnaire (PHQ-
9) 
Kessler Psychological Distress 
scale (K-10) 
Sheehan Disability Scale 
Pre-treatment and post-treatment 
 
 
Change in risk-taking was not a 
significant partial or full mediator 
between the intervention and 
outcome variables, except for 
PHQ-9 scores. 
 
Outcomes measures were not 
significant partial or full 
mediators between treatment and 
change in risk-taking. 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Mediator 
Self-report 
Domain-Specific Risk-Taking 
Scale 
Pre-treatment and post-treatment 
Diagnosis 
Clinician-administered 
MINI Version 5.0.0 (GAD section) 
McEvoy & 
Erceg-Hurn 
2016 
Australia 
Cohort 
study 
 
Group 
MCT for 
GAD 
n = 62 
69% female 
36.6 years (12.3) 
GAD (DSM-IV) 
 
 
 
IU 
 
 
Group 
Metacognitive 
therapy (MCT) 
Outcome 
Self-report 
PSWQ 
Repetitive thinking questionnaire 
(RTQ) 
Pre-treatment, post-treatment, one-
month follow up 
 
Change in IU was associated with 
change in PSWQ and RTQ scores 
over the course of treatment after 
controlling for change in PANAS 
scores.  
 
Change in Prospective IU was a 
statistically significant predictor 
of PSWQ and RTQ scores after 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Mediator 
Self-report 
IUS 12-item version 
Positive and Negative Affect Scale 
(PANAS-NEG subscale) 
Pre-treatment, post-treatment, one-
month follow up 
Diagnosis 
Clinician-administered 
MINI 
Pre-treatment 
controlling for PANAS scores. In 
the same analyses, change in 
inhibitory IU did not reach 
statistical significance. 
McEvoy, 
Erceg-Hurn, 
Anderson, 
Campbell & 
Nathan 
2015 
Cohort 
study 
 
Group 
MCT 
n = 52  
60% female 
38 years (14.3) 
GAD (DSM-IV) 
Metacognitive 
beliefs 
Repetitive 
negative 
thinking 
(RNT) 
Group MCT  
 
Outcome 
Self-report 
K -10 
Assessment, first session, post-
treatment (session 6), follow-up 
(session 7) 
Changes in RNT over treatment 
were associated with changes in 
negative metacognitions and 
changes in distress. Neither 
positive nor negative 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Australia  
 
 
Mediator 
Self-report 
RTQ 
Metacognitions questionnaire-30 
Assessment, first session, post-
treatment (session 6), follow-up 
(session 7) 
Diagnosis 
Clinician-administered 
MINI 
Pre-treatment 
metacognitions were directly 
associated with change in distress. 
Reductions in negative 
metacognitive beliefs were 
associated with reductions in RNT 
which were associated with 
reductions in distress. This was 
not the case for positive 
metacognitions. 
Approximately 25% of the change 
in distress during treatment was 
attributed to the indirect effect of 
negative metacognitions via RNT. 
Only 4% of the change in distress 
during treatment was attributed to 
the indirect effect of positive 
metacognitions via RNT. 
55 
 
Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Millstein, 
Orsillo, 
Hayes-Skelton 
& Roemer 
2015 
RCT 
 
ABBT vs. 
AR 
n = 81 
65.4% female 
32.9 years 
GAD (DSM-IV) 
 
 
Interpersonal 
problems 
 
Mindfulness 
 
 
ABBT (n = 40) 
 
AR (n = 41) 
Outcome 
Clinician-rated 
Clinicians’ Severity Rating for 
GAD - ADIS for DSM-IV 
Pre-treatment, post-treatment, 6- 
and 12-month follow-up 
Mediator 
Self-report 
Inventory of interpersonal problems 
circumplex scales-short form 
Five Facet Mindfulness 
Working Alliance Inventory 
Pre-treatment, post-treatment, 6- 
and 12-month follow-up 
 
 
There were no significant effects 
of pre-treatment interpersonal 
problems on change in GAD 
severity over treatment.  
Post-treatment interpersonal 
problems predicted GAD 
symptom severity at 6- but not 12- 
month follow-up. Post-treatment 
interpersonal problems explained 
9% of the variance in GAD 
severity at 6-month follow-up. 
Increases in mindfulness 
predicted decreases in 
interpersonal problems at post-
treatment, 6- and 12-month follow 
up, over and above the effects of 
changes in GAD severity. Change 
in mindfulness explained 18% of 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Diagnosis  
Clinician-administered 
ADIS for DSM-IV 
the variance in interpersonal 
problems at post-treatment, 22% 
of the variance at 6-month follow-
up and 19% of the variance in 
change in interpersonal problem 
(above change in GAD) severity 
at 12-month follow-up. 
Newman & 
Fisher 
2013 
USA 
RCT 
 
CBT vs. 
CT vs. 
SCD 
n = 76 
68.4% female 
36.6 years (11.56) 
GAD (DSM-IV) 
Duration of 
GAD 
(moderator) 
 
Change in 
rigidity of 
anxiety 
symptoms 
(mediator) 
 
Combined CBT  
(n = 24) 
 
Cognitive 
therapy (CT; n = 
25) 
 
Self-control 
desensitisation 
(SCD; n = 27) 
Outcome 
Clinician-administered 
Clinicians’ Severity Rating for 
GAD - ADIS-Revised 
HARS 
Pre- and post-treatment 
Self-report 
PSWQ 
In the CT and SCD conditions, 
greater GAD duration predicted 
greater flexibility of anxious 
symptoms during treatment, 
which predicted greater reliable 
change at posttreatment.  
In the CBT condition, GAD 
duration predicted less generation 
of flexibility in symptoms, which 
predicted less reliable change at 
posttreatment. 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
State trait anxiety inventory 
(STAI)-trait version 
Pre- and post-treatment 
Mediator 
Self-report 
Client diary: recorded anxiety 
levels 4 times per day (0-100) 
4 times daily 
 
Diagnosis 
Clinician-administered 
ADIS–Revised 
Assessment, 2-weeks post-
assessment 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
Torbit & 
Laposa 2016 
Canada 
Cohort 
study 
 
Group CBT 
n = 81 
35.5 years (11.29) 
GAD (DSM-IV) 
IU 
 
Group CBT 
 
 
Outcome 
Self-report 
PSWQ 
Worry Domains Questionnaire 
DASS 
Pre-and post-treatment 
Mediator 
Self-report 
IUS 
Pre-and post-treatment 
Diagnosis 
Clinician-administered 
Structured Clinical Interview for 
Axis I Disorders (SCID-I) 
Change in IU predicted significant 
change on worry domains, worry 
severity and depression, but not 
anxiety.  
IU accounted for 54.3% of the 
variance in change in worry 
domains, over and above worry 
severity.  
IU accounted for 56.1% of the 
variance in change in worry 
severity, over and above worry 
domains.  
Mediation analyses 
Pre- and post-treatment PSWQ 
scores were mediated by changes 
in IU score. Pre- and post-
treatment worry domain scores 
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Authors 
Year 
Country 
Design 
 
Participant n 
Mean age (SD) 
Gender 
Diagnosis 
Hypothesised 
mediator(s) 
Intervention Measures of outcome, mediator and 
diagnosis 
Frequency of measurement 
Key findings 
were mediated by changes in IU 
score. No mediation effect was 
detected for change in stress, 
depression or anxiety.  
Note. AAQ = Acceptance and Action Questionnaire; ABBT = Acceptance Based Behaviour Therapy; ADIS = Anxiety Disorders Interview Schedule; 
AR = Applied Relaxation;  BAI = Beck Anxiety Inventory; BDI-II = Beck Depression Inventory-II; CBT = Cognitive Behavioural Therapy; DASS = 
Depression Anxiety and Stress Scale; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders 4th edition; EQ = Experiences Questionnaire; 
GAD = Generalised Anxiety Disorder; GAD-Q = Generalised Anxiety Disorder Questionnaire; GAD-7 = Generalized Anxiety Disorder 7-Item Scale; 
HARS = Hamilton Anxiety Rating Scale; IU = Intolerance of Uncertainty; IUS = Intolerance of Uncertainty Scale; K-10 = Kessler Psychological 
Distress Scale; MCT = Metacognitive Therapy; MINI = Mini-International Neuropsychiatric Interview; PANAS = Positive and Negative Affect Scale; 
PHQ-9 = Patient Health Questionnaire; PSWQ = Penn State Worry Questionnaire; QoLI = Quality of Life Inventory; RCT = Randomised Controlled 
Trial; RNT = Repetitive Negative Thinking; RTQ = Repetitive Thinking Questionnaire; STAI = State trait anxiety inventory; VLQ = Valued Living 
Questionnaire; WAQ = Worry and Anxiety Questionnaire. 
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Data assessment and critical appraisal. 
Requirements for mediation research.  
Critical appraisal reviewing the extent to which studies met the recommended 
criteria for assessing potential mediators is outlined in Table 4.  
Eleven of the 15 studies used statistical mediation analysis, using statistical 
methods outlined by various groups (Baron & Kenny, 1986; Bauer, Preacher, & Gil, 
2006; Cole & Maxwell, 2003; A. F. Hayes, 2013; Hedeker & Gibbon, 2006; Hu & 
Bentler, 1998; Kenny, Korchmaros, & Bolger, 2003; Kraemer et al., 2002; Preacher & 
Kelley, 2011; Sobel, 1982). Mediational effects were estimated using multilevel 
mediation procedures, growth curve modelling, hierarchical regression and structural 
equation modelling.  
As recommended by Kazdin (2007), after statistical mediation analysis it should 
be determined whether studies meet the additional criteria for identifying a potential 
mediator. Four of the 15 studies met the temporality criterion through assessing both 
the mediator and outcome variables at three or more time points during the treatment 
phase (Bomyea et al., 2015; Donegan & Dugas, 2012; Dugas et al., 2009; Dugas & 
Ladouceur, 2000). Four further studies assessed the hypothesised mediator at three or 
more time points during the treatment phase, but the outcome variables were measured 
at pre- and post-treatment only (Beesdo-Baum et al., 2012; Eustis et al., 2016; Hayes-
Skelton et al., 2015; Newman & Fisher, 2013). Assessment of both the mediator and 
outcome variables should occur during the treatment phase in order to meet the 
temporality criterion (Kazdin, 2007; Laurenceau et al., 2007). The seven remaining 
studies included only pre-treatment, post-treatment and some included follow-up 
assessments, with no assessment of either the mediator or outcome variables during the 
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treatment phase (Gallagher et al., 2014; Hayes et al., 2010; Lorian et al., 2012; McEvoy 
& Erceg-Hurn, 2016; McEvoy et al., 2015; Millstein et al., 2015; Torbit & Laposa, 
2016). Assessing the variables at pre- and post-treatment allows conclusions to be 
drawn about whether the proposed mediator correlates with outcomes, predicts change 
in outcome, or explains a portion of the variance in symptom change but does not allow 
for conclusions to be drawn about causality and whether change in the proposed 
mediator precedes changes in the outcome variable (Lemmens et al., 2016). 
Only one study used an approach where the mediator was experimentally 
manipulated (Gallagher et al., 2014); the hypothesised mediator was perceived control 
and participants chose whether to initiate CBT, which modified their perceptions of 
control. Without experimental manipulation of the hypothesised mediator alternative 
explanations for associations between the proposed mediator and outcome cannot be 
ruled out (Kazdin, 2007). 
Nine of the 15 studies were designed in such a way that they were able to assess 
specificity (Beesdo-Baum et al., 2012; Donegan & Dugas, 2012; Dugas et al., 2009; 
Eustis et al., 2016; Hayes-Skelton et al., 2015; Hayes et al., 2010; McEvoy et al., 2015; 
Millstein et al., 2015; Newman & Fisher, 2013) either through assessing multiple 
mediators or using two or more treatments with differing theorised processes (Holmes 
et al., 2018). All other studies investigated one mediator and one treatment approach.  
Ten of the 15 studies used well established, valid and reliable measures that are 
sensitive to change to assess outcome and mediator variables. Where studies were 
assessed as not using valid and reliable measures this was where a self-monitoring diary 
was used to measure the outcome or mediator variables and validity and reliability were 
not reported (Donegan & Dugas, 2012; Dugas et al., 2009; Dugas & Ladouceur, 2000) 
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or where the validity and reliability are neither reported in the article nor clearly stated 
in the published literature (Gallagher et al., 2014; Millstein et al., 2015). 
No studies reported a power calculation to determine adequate sample size; 
however, Hayes et al. (2010) note in their discussion that their analysis had low 
statistical power. Lemmens et al. (2016) define a sufficient sample size as 40 or greater 
in each condition, therefore this recommendation was used as a baseline for the 
assessment of adequacy of sample size. Six of the 15 studies had 40 or more participants 
per condition (Eustis et al., 2016; Gallagher et al., 2014; McEvoy & Erceg-Hurn, 2016; 
McEvoy et al., 2015; Millstein et al., 2015; Torbit & Laposa, 2016). However, it should 
be noted that Dugas and Ladouceur (2000) and Dugas et al. (2009) completed multiple 
baseline single case designs; therefore, although the sample size would be deemed 
insufficient for mediation analysis and to generalise the findings, this was appropriate 
for their aims. All studies concluded that larger sample sizes would be recommended 
for future research. All studies selected the hypothesised mediators from cognitive 
behavioural theory or theoretical models of GAD and therefore had a plausible and 
coherent explanation for how the proposed mediator operates. 
 Kazdin (2007) recommends that the strength of the argument for a proposed 
mediator should be based on the combination of these criteria. The total number of 
criteria met by each study was therefore reviewed. No studies met all the recommended 
criteria required for assessment of a potential mediator, as can be seen in Table 4. Two 
studies met five of the seven criteria (Eustis et al., 2016; McEvoy et al., 2015), eight 
studies met four criteria (Bomyea et al., 2015; Donegan & Dugas, 2012; Dugas et al., 
2009; Gallagher et al., 2014; Hayes-Skelton et al., 2015; Hayes et al., 2010; Newman 
& Fisher, 2013; Torbit & Laposa, 2016), four studies met three of the criteria (Beesdo-
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Baum et al., 2012; Lorian et al., 2012; McEvoy & Erceg-Hurn, 2016; Millstein et al., 
2015), and one study met two of the criteria (Dugas & Ladouceur, 2000). The number 
of studies meeting each of the criterion can be found in Table 5. The only criterion that 
all studies met was a plausible and coherent explanation for the operation of the 
proposed mediator.  
Fidelity to the intervention. 
Seven studies reported on treatment adherence and all reported high levels of 
adherence to the treatment protocol (Beesdo-Baum et al., 2012; Bomyea et al., 2015; 
Dugas et al., 2009; Dugas & Ladouceur, 2000; Eustis et al., 2016; Hayes-Skelton et al., 
2015; Millstein et al., 2015). Three studies did not report on treatment adherence but 
highlighted that treatment was delivered by licenced and trained psychologists 
(Donegan & Dugas, 2012; McEvoy & Erceg-Hurn, 2016; McEvoy et al., 2015). Four 
studies did not report on treatment adherence or competence of therapists (Gallagher et 
al., 2014; Hayes et al., 2010; Newman & Fisher, 2013; Torbit & Laposa, 2016). Lorian 
et al. (2012) examined internet CBT, therefore all participants received the same 
intervention in the same manner.  
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Table 4 
Extent to which studies met recommended criteria for mediation research 
Study Analysis 
 
Statistical 
mediation 
analysis 
Temporality Experimental 
manipulation 
of mediator 
Specificity Valid & 
reliable 
measures 
Adequate 
sample size 
Plausible 
processes 
Number 
of criteria 
met 
Beesdo-
Baum et al. 
(2012) 
Regression analysis 
 
 
- - outcome 
+ mediator 
- 
 
+ + - + 3 
Bomyea et 
al. (2015) 
Multilevel mediation 
models 
 
Bauer et al. (2006); 
Kenny et al. (2003) 
+ + - - + - + 4 
Donegan 
and Dugas 
(2012) 
Multilevel mediation 
models 
 
Kenny et al. (2003) 
+ + - + - - + 4 
Dugas et al. 
(2009) 
Multivariate time series 
analysis 
 
Tiao and Box (1981) 
+ + - + - - + 4 
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Study Analysis 
 
Statistical 
mediation 
analysis 
Temporality Experimental 
manipulation 
of mediator 
Specificity Valid & 
reliable 
measures 
Adequate 
sample size 
Plausible 
processes 
Number 
of criteria 
met 
Dugas and 
Ladouceur 
(2000) 
 
Time-series analysis  
 
Box and Jenkins (1970) 
- + - - - - + 2 
Eustis et al. 
(2016) 
Growth curve modelling 
Kraemer et al. (2002) 
+ - outcome 
+ mediator 
- + + + + 5 
Gallagher 
et al. 
(2014) 
Latent growth curve 
models 
Hu and Bentler (1998) 
+ - + - - + + 4 
Hayes et al. 
(2010) 
 
Latent growth curve 
modelling 
Logistic regression 
+ - - + + - + 4 
Hayes-
Skelton et 
al. (2015) 
Latent growth curve 
modelling 
Bivariate latent 
difference score model 
+ - outcome 
+ mediator 
- + + - + 4 
Lorian et 
al. (2012) 
Mediation analyses + - - - + - + 3 
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Study Analysis 
 
Statistical 
mediation 
analysis 
Temporality Experimental 
manipulation 
of mediator 
Specificity Valid & 
reliable 
measures 
Adequate 
sample size 
Plausible 
processes 
Number 
of criteria 
met 
Baron and Kenny (1986) 
Sobel (1982) 
McEvoy 
and Erceg-
Hurn 
(2016) 
Mixed-effect regression 
models 
Hedeker and Gibbon 
(2006) 
- - - - + + + 3 
McEvoy et 
al. (2015) 
Longitudinal modelling 
 
A. F. Hayes (2013); 
Preacher and Kelley 
(2011) 
+ - - + + + + 5 
Millstein et 
al. (2015) 
Mixed-effect regression 
models 
 
Hedeker and Gibbon 
(2006) 
- - - + - +  + 3 
Newman 
and Fisher 
(2013) 
Path models (structural 
equation modelling) 
 
+ - outcome 
+ mediator 
- + + - + 4 
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Study Analysis 
 
Statistical 
mediation 
analysis 
Temporality Experimental 
manipulation 
of mediator 
Specificity Valid & 
reliable 
measures 
Adequate 
sample size 
Plausible 
processes 
Number 
of criteria 
met 
Baron and Kenny 
(1986); Cole and 
Maxwell (2003); 
Kraemer et al. (2002) 
Torbit and 
Laposa 
(2016) 
Linear regression 
analyses   
Mediation analyses 
 
A. F. Hayes (2013) 
+ - - - + + + 4 
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Table 5 
Number of studies meeting the recommended criteria for mediation research 
Requirement N (%) 
Statistical mediation analysis 11 (73.3)   
Temporality 4 (26.7) 
Experimental manipulation of mediator 1 (6.7) 
Specificity 9 (60.0) 
Valid and reliable measures 10 (66.7) 
Adequate sample size 6 (40.0) 
Plausible processes 15 (100.0) 
 
Data synthesis. 
Of the 15 identified studies, 13 concluded that the hypothesised mediator was 
associated with change in GAD outcomes following therapy. Two did not find a relation 
between the proposed mediators and GAD symptoms. Beesdo-Baum et al. (2012) 
concluded that cognitive and behavioural avoidance, safety behaviours and 
reassurance-seeking measured weekly during treatment were not associated with GAD 
symptoms at post-treatment. Lorian et al. (2012) concluded that changes in risk-taking 
did not mediate change in symptoms of GAD over the course of internet CBT.  
However, both studies had a small sample size therefore it may be that the studies were 
not sufficiently powered to detect an effect.  
Intolerance of uncertainty model. 
The mediators examined were diverse and only intolerance of uncertainty and 
two other processes were examined in more than one study. Studies suggested that 
intolerance of uncertainty is a mediator of therapeutic change. It was shown that change 
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in intolerance of uncertainty statistically mediated change in worry in CBT (Bomyea et 
al., 2015; Torbit & Laposa, 2016) and that change in intolerance of uncertainty precedes 
change in worry but change in worry does not precede change in intolerance of 
uncertainty (Dugas & Ladouceur, 2000). Bomyea et al. (2015) demonstrated that 
reductions in intolerance of uncertainty accounted for 59% of the reduction in worry 
over the course of CBT, but that reductions in worry accounted for less than 1% of the 
change in intolerance of uncertainty. However, the sample size in this study was small 
which limited the generalisability of these findings. McEvoy and Erceg-Hurn (2016) 
demonstrated that reduction in intolerance of uncertainty was associated with 
reductions in GAD symptoms in metacognitive therapy; however, when separating 
intolerance of uncertainty into prospective and inhibitory intolerance of uncertainty, 
only prospective intolerance of uncertainty was shown to be a significant predictor of 
GAD symptomatology. Together, these studies met the criteria for statistical mediation 
analysis (Bomyea et al., 2015; Torbit & Laposa, 2016), assessment of temporality 
(Bomyea et al., 2015; Dugas & Ladouceur, 2000), used valid and reliable measures 
(Bomyea et al., 2015; McEvoy & Erceg-Hurn, 2016; Torbit & Laposa, 2016) and two 
had an adequate sample size (McEvoy & Erceg-Hurn, 2016; Torbit & Laposa, 2016). 
However, these studies did not experimentally manipulate intolerance of uncertainty 
and did not meet the specificity criterion, therefore alternative explanations for the 
relationship between treatment, GAD symptom severity and intolerance of uncertainty 
cannot be ruled out, and it is possible that other processes may play a mediational role 
in the relationship between treatment and outcomes.  
This provides support for the intolerance of uncertainty model of GAD and 
indicates that modifying cognitions, specifically those related to uncertainty, is likely 
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to be important in cognitive-behavioural treatments for GAD. McEvoy and Erceg-Hurn 
(2016) provide preliminary evidence that modifying the desire for predictability 
(prospective intolerance of uncertainty) might lead to greater change in symptoms than 
modifying uncertainty paralysis (inhibitory intolerance of uncertainty). Prospective 
intolerance of uncertainty is a more cognitive process than inhibitory intolerance of 
uncertainty, which reflects more behavioural processes, providing further support for 
focusing on cognitive processes in cognitive-behavioural treatments for GAD. 
Metacognitive model. 
In line with the metacognitive model, McEvoy et al. (2015) examined positive 
and negative metacognitive beliefs and repetitive negative thinking in group 
metacognitive therapy. It was concluded that positive and negative metacognitions 
were not directly associated with change in psychological distress, however changes in 
repetitive negative thinking were associated with changes in positive and negative 
metacognitions and psychological distress. Repetitive negative thinking was shown to 
statistically mediate the relationship between negative metacognitions and change in 
psychological distress over the course of treatment and approximately 25% of the 
change in distress was attributable to this relationship. There was no significant impact 
of negative metacognitions on change in distress through any other evaluated mediator 
and no significant relationship was found between positive metacognitions and distress, 
even via repetitive negative thinking. This study was one of the higher quality studies, 
meeting five of the seven criteria recommended for mediation research which 
strengthens the argument for repetitive negative thinking as a mediator of treatment 
outcomes. However, the temporality criterion was not met therefore the temporal 
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relationship between these variables cannot be confirmed and it cannot be excluded that 
change in psychological distress preceded changes in repetitive negative thinking. 
This provides further support for the role of cognitive processes in GAD 
treatment outcomes. This study suggests that targeting repetitive negative thinking in 
therapy may be more important than working directly with metacognitions as neither 
positive nor negative metacognitions were directly associated with change in 
psychological distress over the course of treatment. However, the authors conclude that 
by targeting negative metacognitions in treatment this reduces repetitive negative 
thinking and subsequently psychological distress. However, the temporal relationship 
between variables was not established and there are likely to be other mediators that 
also contribute to reductions in psychological distress; change in repetitive negative 
thinking accounted for 25% of the change in distress.  
Acceptance-based model. 
Processes from the acceptance-based model of GAD were examined in four 
studies and were shown to be related to GAD outcomes in ABBT and AR. These 
processes were experiential avoidance, decentering, acceptance of internal experiences, 
engagement in valued action and mindfulness. 
Eustis et al. (2016) demonstrated that experiential avoidance significantly 
predicted change in GAD symptoms and quality of life in both ABBT and AR. This 
was one of the higher quality studies in this review, meeting five of the seven 
recommendations for identifying a mediator, see Table 4. However, although 
experiential avoidance is theoretically related to ABBT, its mediational role was not 
specific to ABBT as this also mediated outcomes in AR. Decentering was also shown 
to be associated with change in GAD symptoms and it was suggested that changes in 
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decentering preceded changes in GAD symptoms within both ABBT and AR (Hayes-
Skelton et al., 2015). These studies used statistical mediation analyses, however the 
outcome measures were only administered at pre- and post-treatment, therefore the 
temporality criterion was not met. It therefore cannot be excluded that changes in the 
outcome measure preceded changes in the mediator during the treatment phase.  
Hayes et al. (2010) demonstrated that change in acceptance of internal 
experiences and engagement in valued action significantly predicted response to 
ABBT, but only change in acceptance of internal experiences predicted post-treatment 
quality of life. Although statistical mediation analysis was completed, both mediator 
and outcome variables were only measured at pre- and post-treatment. Conclusions can 
therefore be drawn about the predictive role of the proposed mediators in response to 
treatment and quality of life, but not whether these mediate changes in symptoms over 
the course of therapy. Sample size was also small in this study, limiting the 
generalisability of conclusions.  
When looking at mindfulness as a potential mediator of outcomes in ABBT and 
AR, an increase in mindfulness was shown to explain 18% of the variance in 
interpersonal problems at post-treatment. Post-treatment interpersonal problems 
subsequently explained 9% of the variance in GAD severity at 6-months post-treatment 
(Millstein et al., 2015). The authors conclude that, despite the theoretical links between 
mindfulness and ABBT, the effects of mindfulness on interpersonal problems was 
similar in both ABBT and AR. However, in reviewing the results section, there is not a 
clear differentiation between results from ABBT and those from AR. Statistical 
mediation analysis was not carried out, therefore conclusions relate to the predictive 
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value of mindfulness on outcomes, rather than its mediational role over the course of 
treatment. 
These studies concentrated on three key theoretical components of the 
acceptance-based model of GAD; internal experiences, the relationship with internal 
experiences and experiential avoidance. This is an emotional and experiential model, 
which is in contrast to the primarily cognitive intolerance of uncertainty and 
metacognitive models. Together, these studies provide evidence of an association 
between change in acceptance-based processes over treatment and treatment outcomes 
for GAD, where improvement in scores for the mediator variable are related to 
enhanced therapeutic outcomes, suggesting that these might be important processes to 
target in treatment. These studies indicate that both AR and ABBT influence change in 
acceptance-based processes. However, without assessment of the temporal relationship 
between the mediator and outcome variables, causality cannot be established therefore 
it is not known whether change in the proposed mediator led to change in symptoms or 
vice versa. 
General cognitive and behavioural processes. 
Change in worry and change in somatic anxiety were examined in two studies 
and were shown to be associated with treatment outcomes. Donegan and Dugas (2012) 
demonstrated that in CBT change in worry accounted for 49.45% of the change in 
symptoms of somatic anxiety and change in somatic anxiety accounted for 57.76% of 
the change in worry. In AR, change in worry accounted for 25.87% of the variance in 
somatic anxiety and change in somatic anxiety accounted for 48.57% of the change in 
worry. These results were supported by Dugas et al. (2009) who, in a multiple baseline 
single case series study, demonstrated that change in worry predicted change in somatic 
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anxiety and vice versa in both CBT and AR. Both studies examined the mediator and 
outcome variables weekly during the treatment phase therefore were able to draw 
conclusions about the temporal relationship between variables. However, both studies 
used a daily self-monitoring booklet to measure variables, of which the validity and 
reliability was unclear. The specificity of the proposed mediators were reviewed, 
however both studies had small sample sizes, limiting the generalisability of these 
findings.   
These findings suggest that treatment strategies targeting worries and/or 
physical sensations (somatic anxiety) may be important in treatment for GAD. This 
may also help to explain why both CBT and AR are effective treatments for GAD, as 
CBT would typically focus on worries and AR on somatic anxiety. 
 Gallagher et al. (2014) suggested that perceived control was a potential 
statistical mediator in the relationship between CBT treatment and GAD symptom 
severity, where changes in perceived control between pre-treatment and post-treatment 
follow-up predicted changes in GAD symptom severity. Statistical mediation analysis 
was completed, and this was the only study to experimentally manipulate the proposed 
mediator. However, similar to other studies, the mediator and outcome variables were 
only measured at pre- and post-treatment, limiting our understanding of the temporal 
nature of the relationship between treatment, mediator and outcome.  
 Newman and Fisher (2013) looked at the interaction between the moderator of 
GAD duration and the mediator of change in rigidity (or flexibility) of anxiety across 
CBT, cognitive therapy (CT) and self-control desensitisation (SCD). Changes in 
rigidity looked at patterns of rigidity and flexibility in symptoms of anxiety. These 
patterns were assessed through entries in a daily diary where participants recorded their 
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anxiety levels four times daily. In the component treatments, CT and SCD, greater GAD 
duration at pre-treatment predicted greater flexibility in anxious symptoms during 
treatment, which in turn predicted a significantly greater reliable change at post-
treatment. In CBT, greater GAD duration predicted less flexibility in anxious symptoms 
during treatment which, in turn, predicted less reliable change at post-treatment. A 
strength of this study was in evaluating the specificity of the proposed mediator in CBT 
and its component treatments (CT and SCD), which highlighted the differential role of 
flexibility of anxious symptoms in CBT vs. CT and SCD. However, outcomes were 
only assessed at pre- and post-treatment, therefore assessing these regularly during the 
treatment phase, alongside the mediator, would strengthen the argument for the role of 
this mediator in treatment outcomes and allow an understanding of the direction of the 
relationship between mediator and outcome variables.  
 
 
 
 
 
 
 
 
76 
 
Discussion 
This review aimed to provide an understanding of the empirical research 
examining mediators of change in cognitive behavioural therapies for generalised 
anxiety disorder. It aimed to identify potential mediators examined in empirical 
research and review the extent to which studies met the recommended criteria for tests 
of treatment mediation, specified by Kazdin (2007). Fifteen studies were identified in 
a systematic literature search. These studies examined 17 potential mediators across 
seven therapeutic approaches. The majority of these studies concluded that the 
hypothesised mediator was associated with change in outcomes, however studies varied 
in the specific conclusions they were able to draw, for example whether the proposed 
mediator was associated with change, its predictive value, or its specific mediational 
role over the course of treatment.  
None of the studies met all the requirements for tests of treatment mediation, 
primarily because they did not assess the temporal relationship between change in the 
hypothesised mediator and change in outcomes and did not experimentally manipulate 
the proposed mediator. However, it is thought that the external validity of studies that 
are able to experimentally manipulate the proposed mediator, while keeping other 
processes content, is likely to be limited (Lemmens et al., 2016). Further, sample size 
was a challenge in the majority of studies, with 60% of studies having less than 40 
participants per condition and all studies concluding that future research should include 
larger sample sizes. These findings are similar to other systematic reviews of 
mediational research; for example, in a recent review on mechanisms of therapeutic 
change in depression, Lemmens et al. (2016) concluded that the studies they reviewed 
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had also been limited in meeting the temporality criterion and none had experimentally 
manipulated the mediator variable.  
The mediators investigated across the studies were heterogenous and only 
intolerance of uncertainty, change in worry and change in somatic anxiety were 
examined in more than one study. Considering the consistency criterion outlined by 
Kazdin (2007), these studies provide promising evidence for the mediational role of 
intolerance of uncertainty, change in worry and change in somatic anxiety in cognitive 
behavioural treatment outcomes, suggesting it is likely to be important to consider and 
work to modify these processes in treatment for GAD. However, studies examining 
change in worry and change in somatic anxiety had small sample sizes, limiting the 
generalisability of these findings and meaning that replication in larger scale studies is 
warranted. Studies examining intolerance of uncertainty only examined this process as 
a potential mediator, therefore it would be helpful in future research to include other 
potential mediators to examine whether associations between the intervention and 
outcome are specific to intolerance of uncertainty or whether multiple mediators 
account for the change. McEvoy and Erceg-Hurn (2016) separated intolerance of 
uncertainty into prospective and inhibitory intolerance of uncertainty and found 
differential effects on outcomes. It may therefore be interesting for future research to 
examine different subscales within the construct of intolerance of uncertainty.  
Other processes identified as being associated with treatment outcomes were 
processes related to the acceptance-based model of GAD (experiential avoidance, 
decentering, acceptance of internal experiences, engagement in valued action and 
mindfulness), repetitive negative thinking, perceived control and change in rigidity of 
anxiety symptoms. Each of these mediators was only investigated in one study, limiting 
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the general conclusions that can be drawn about the mediational role of these processes 
in treatment outcomes. Given that associations were found between these hypothesised 
mediators and outcomes and that they related to theoretical models, these processes 
warrant further investigation, particularly in larger studies where both the mediator and 
outcome variables are measured on multiple occasions during the treatment phase.  
For the processes related to the acceptance-based model of GAD, three of the 
four studies reviewed mediators in both ABBT and AR. Although the hypothesised 
mediators were theoretically related to ABBT, there were no observed differences in 
the role of the mediator variables across the two treatments. Holmes et al. (2018) 
suggest that specificity can be demonstrated where there is a stronger mediation via the 
hypothesised mediator for a theoretically associated treatment than for an intervention 
that is not theoretically relevant. These findings therefore suggest that these 
hypothesised mediators do not have a specific, causal role in mediating treatment 
outcomes. There is preliminary evidence suggesting that these processes are associated 
with treatment outcomes, however replication in studies assessing temporality and with 
larger sample sizes is recommended.  
There are several theoretical models of GAD, which encompass a range of 
psychological processes and point towards a number of potential mediators, as outlined 
in the introduction. When assessing mediators of therapeutic change, it is important to 
first assess theorised processes (Kazdin, 2007). The mediators examined across the 
studies in this review were related to four of the theoretical models of GAD and more 
general cognitive behavioural theory. However, there remain some theorised processes 
for which the mediational role is yet to be examined empirically, these include negative 
problem orientation, coping, and those related to the emotion dysregulation model 
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including emotional hyperarousal, understanding of emotions, cognitive reactions to 
emotions, and emotion regulation abilities.  
All studies examined in this review were carried out in the Western world, 
which is largely reflective of efficacy studies of psychological interventions. It is 
therefore possible that differences in mediational processes in psychological treatments 
may be found if studies were carried out in different settings. The majority of studies 
were carried out in the context of outpatient clinics within university settings and 
exclusion criteria typically included suicidal intent, substance use, bipolar disorder or 
psychotic disorder. Although these are standard exclusion criteria for research trials, 
this may not reflect the reality of everyday clinical practice, potentially limiting the 
generalisability of these finding for routine practice.  
Limitations. 
This review attempted to comprehensively search the published literature, 
however unpublished research was not included in the review. Publication bias was 
therefore not accounted for. In addition, a second reviewer was not available for the 
article selection process and for data assessment and critical appraisal. One reviewer 
therefore completed these processes, which increases the risk of bias in the selection of 
studies and critical appraisal process. 
This review examined psychological mediators, therefore did not include 
possible mediators from other categories outlined in the introduction such as biological, 
social, or those related to the therapist. It is highly likely that other processes play a role 
in mediating treatment outcomes and indicate additional mechanisms of psychological 
treatments (Holmes et al., 2018), which it was beyond the scope of this review to assess. 
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Furthermore, mediators are likely to interact with moderators, which highlight the 
conditions under which a particular intervention may be more effective. For example, 
attachment style has been shown to be a moderator of treatment outcome in people with 
generalised anxiety disorder (Newman, Castonguay, Jacobson, & Moore, 2015). This 
review was not able to include moderators and develop an understanding of their 
interaction with mediators of outcome, therefore in future reviews understanding 
moderators and their interaction with treatment mediators may be important. 
Recommendations for future research. 
 Future research would benefit from refinement of research methodology, in line 
with criteria required for mediational research, increased homogeneity in theorised 
processes examined and further understanding of the interactions between potential 
mediators and moderators. 
Future research examining mediators of therapeutic change should focus on 
establishing the temporal relationship between mediator and outcome variables. This 
can be achieved through examining both mediator and outcome variables at multiple 
time points throughout treatment. Recommendations are that this should ideally be 
every session (Holmes et al., 2018), however this can be difficult in practice, and study 
design should be balanced with the burden for study participants. Lemmens et al. (2016) 
suggest that Experience Sampling Methodology might be a promising way to support 
this approach and with the increasing use of smartphone technology this might be an 
increasingly accessible method (W. Hofmann & Patel, 2015; Raento, Oulasvirta, & 
Eagle, 2009). Furthermore, sample size is a limitation in current research, therefore it 
is important that future research examining treatment mediators is conducted in the 
context of adequately powered studies (Holmes et al., 2018). 
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 Given the heterogeneity of the current literature, with only intolerance of 
uncertainty, change in worry and change in somatic anxiety being examined in more 
than one study, future research would benefit from building on the current evidence-
base by examining potential mediators already shown to be associated with treatment 
outcomes and addressing methodological limitations of previous studies. Where 
mediators are tested that have not yet been examined in empirical research 
recommendations emphasise that these should be selected from theory (Kazdin, 2007; 
Lemmens et al., 2016).  
 In future research it is also important to understand the specificity of 
hypothesised mediators and the differential contributions of different mediators across 
various treatments. Understanding how different variables moderate outcomes and their 
influence on mediators would also be an interesting development in future research. For 
example, understanding the role of culture as a potential moderator of outcomes and 
whether this differentially effects how a treatment works has the potential to enhance 
understanding of transcultural therapy and inform effective adaptations. This may go 
some way in addressing the limitation of the majority of studies being carried out in the 
Western world.  
Theoretical implications. 
As previously outlined, mediators examined in studies included in this review 
related to four of the key theoretical models of GAD (the intolerance of uncertainty, 
metacognitive, acceptance-based and avoidance models) and the more general 
cognitive behavioural model. Although all focus on cognitive and behavioural 
processes, each has a varying focus on the key mechanisms contributing to the 
development and maintenance of GAD, as outlined in the introduction. In addition, 
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there has been some debate in the broader cognitive-behavioural literature regarding 
the relative importance of cognitive and behavioural processes in the development, 
maintenance and treatment of psychiatric disorders (e.g. Hofmann, 2008; Longmore & 
Worrell, 2007).  
The studies included in this review highlighted a mediational role for 
intolerance of uncertainty in treatment outcomes and a relationship between negative 
metacognitive beliefs, repetitive negative thinking and treatment outcomes, supporting 
theories suggesting a key role for cognitive processes in the development, maintenance 
and treatment of GAD. Furthermore, refinement of our understanding of cognitive 
processes, such as examining prospective and inhibitory intolerance of uncertainty, 
within the construct of intolerance of uncertainty (McEvoy & Erceg-Hurn, 2016), was 
also indicated to be important. 
In this review, it was concluded that intolerance of uncertainty, change in worry 
and change in somatic anxiety were shown to mediate treatment outcomes. These 
related to more traditional cognitive behavioural theories, providing further support for 
these theories of GAD. A relatively more recent theoretical model of GAD is the 
acceptance-based model (Roemer & Orsillo, 2002). Although it could not be concluded 
in this review that acceptance-based processes mediated treatment outcomes, this was 
primarily due to methodological limitations of studies, rather than lack of empirical 
support for the theory. Tentatively, these studies provided preliminary support for third-
wave theoretical approaches for GAD and further research may provide further 
evidence for their role in the development, maintenance and treatment of GAD. 
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Clinical implications. 
 The studies included in this review focused on various mediators, including 
cognitive, emotional and experiential processes and indicated that changes in these 
processes were associated with treatment outcomes. This indicated several processes 
that it might be important to target in treatment. Intolerance of uncertainty was found 
to be a mediator of treatment outcomes, providing further empirical support for the 
intolerance of uncertainty model of GAD. It is therefore likely to be important to 
address this in treatment and there is preliminary research indicating that examining 
different subscales of intolerance of uncertainty is important. However, the specificity 
of intolerance of uncertainty as a mediator was not tested and other studies indicated 
that further processes were associated with treatment outcomes. Change in worry and 
change in somatic anxiety were also shown to mediate treatment outcomes, therefore 
treatment strategies targeting these processes may also be important in treatment for 
GAD. However, these studies had small sample sizes which limited their 
generalisability beyond the study sample. Although further research is required to 
examine the mediational role of different processes in treatment for GAD, it is likely 
that a combination of factors mediate outcomes and therefore should be targeted in 
treatment.  
Conclusions. 
This review attempted to provide a comprehensive understanding of the current 
status of empirical research examining psychological mediators of change in cognitive 
behavioural therapies for generalised anxiety disorder. Intolerance of uncertainty, 
change in worry and change in somatic anxiety were the only mediators examined in 
more than one study and the extent to which studies met the recommended requirements 
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for mediation analysis was variable. One of the biggest challenges in mediation research 
is demonstrating the causal relation between change in the proposed mediator and 
change in GAD symptoms and it will therefore be important for future research to 
address this.  
An empirical research base for mechanisms of change in cognitive behavioural 
treatments is growing, however it is important for future studies to continue to focus on 
theorised processes while addressing current methodological limitations, including the 
temporal relationship between change in the proposed mediator and change in 
outcomes, and the specificity of proposed mediators within adequately powered studies. 
Improving understanding of processes that mediate outcomes in therapy has 
considerable potential to refine existing treatments for improved efficacy and inform 
the development of new treatment approaches. 
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Empirical Article - Cognitive Predictors of Outcome in Cognitive Behavioural 
Therapy: the Role of Attitudes and Beliefs 
Abstract 
Cognitive Behavioural Therapy (CBT) has been shown to be an effective 
treatment for a range of mental health difficulties. However, there is considerable 
variation in response to CBT and there remain subgroups of people for whom CBT does 
not lead to recovery. Factors that predict treatment outcomes are less well understood 
than the efficacy of treatments and research to date has focused more on demographic 
and symptom-specific predictors than theorised psychological processes. 
Understanding predictors of outcome has the potential to identify people at risk of poor 
prognosis, understand differential responses to treatment, guide case formulation and 
inform the selection of appropriate treatments and treatment strategies to personalise 
interventions.  
This study examined cognitive predictors of treatment outcomes in CBT for 
depression and anxiety disorders in the pragmatic context of an Improving Access to 
Psychological Therapies (IAPT) service. Predictors assessed were depression and 
anxiety related attitudes and beliefs. Outcomes were depression and anxiety symptom 
severity, caseness (whether scores were below the clinical cut-off at post-treatment), 
clinically significant improvement, reliable improvement and reliable and clinically 
significant improvement.  
It was found that pre-treatment attitudes and beliefs did not predict treatment 
outcomes. Pre-treatment level of maladaptive attitudes and beliefs may have a less 
important role in predicting outcomes and it might be that change in these processes 
over treatment is more important. However, there were limitations to this study 
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including the sample size, which limited the conclusions that could be drawn and the 
generalisability of findings. There is an ongoing need to develop an understanding of 
factors that contribute to differential treatment responses to enhance treatment efficacy 
and it is important that future research continues to examine the predictive role of 
theorised processes through empirical research.  
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Introduction 
 The efficacy of psychotherapy, particularly Cognitive Behavioural Therapy 
(CBT), for the treatment of depressive and anxiety disorders has largely been supported 
(Butler, Chapman, Forman, & Beck, 2006; Carpenter et al., 2018; Hofmann, Asnaani, 
Vonk, Sawyer, & Fang, 2012; Hofmann & Smits, 2008; Olatunji, Cisler, & Deacon, 
2010). CBT is recommended by national guidelines in the UK as a first-line treatment 
for depression (National Institute for Health and Care Excellence (NICE), 2009), 
anxiety disorders including Generalised Anxiety Disorder (GAD; NICE, 2011), Panic 
Disorder (NICE, 2011) and Social Anxiety Disorder (NICE, 2013), Obsessive 
Compulsive Disorder (OCD; NICE, 2005a) and Post-Traumatic Stress Disorder 
(PTSD; NICE, 2005b). However, despite the demonstrated efficacy of cognitive-
behavioural interventions, less is understood about the mechanisms that predict or 
underlie therapeutic change (Holmes et al., 2018; McMain, Newman, Segal, & 
DeRubeis, 2015), including the extent to which psychological processes or specific 
components of therapy influence symptom change (Lorenzo-Luaces, German, & 
DeRubeis, 2015). 
Research into the efficacy of CBT has demonstrated considerable variation in 
response, with response rates ranging from 38% to 82% (Hofmann et al., 2012). A 
recent meta-analysis examining remission in CBT for anxiety disorders found the 
overall mean remission rate to be 51% and suggested that there is room for 
improvement in recovery rates (Springer, Levy, & Tolin, 2018). There is also increasing 
evidence for negative effects of psychological treatment (Crawford et al., 2016) and 
research has demonstrated differential treatment responses for subgroups of individuals 
(Huibers et al., 2015). Findings such as these have stimulated interest in personalised 
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medicine: using an individual’s idiosyncratic characteristics to adapt interventions for 
optimal efficacy (Schneider, Arch, & Wolitzky-Taylor, 2015). 
Understanding moderators or predictors of treatment outcome are a basis for 
personalising treatment. Treatment moderators identify for whom and under what 
conditions a treatment is likely to work (Kraemer, Wilson, Fairburn, & Agras, 2002), 
and can potentially identify people at risk of poor prognosis, guide case formulation, 
support clinicians in selecting appropriate treatments and treatment strategies for 
individuals and improve understanding of differential treatment responses (Kraemer et 
al., 2002; McMain et al., 2015; Wiles et al., 2014). Furthermore, this has the potential 
to inform the verification and development of theories and facilitate the refinement and 
improvement of psychological therapies to improve efficacy (Holmes et al., 2018; 
Lemmens, Müller, Arntz, & Huibers, 2016).  
 Kyrios, Hordern, and Fassnacht (2015) suggest that predictor variables fall into 
eight broad categories: demographic variables, symptom characteristics (e.g., severity), 
comorbidity, cognitive variables, motivational factors (e.g., treatment expectations), 
treatment factors (e.g., therapeutic relationship, engagement in therapy), biological 
factors and other (e.g., social factors, personality). Research into predictors of 
therapeutic outcomes has typically focused on common or more general factors such as 
demographic or symptom-specific variables but is now increasingly focused on 
psychological predictors and factors specific to theoretical models, for example 
cognitive processes such as dysfunctional beliefs (Crits-Christoph, Connolly Gibbons, 
& Mukherjee, 2013; Knopp, Knowles, Bee, Lovell, & Bower, 2013; Llewelyn, 
Macdonald, & Aafjes-Van Doorn, 2016). In outlining key requirements for research 
into moderators and mediators of treatment outcomes, Kraemer et al. (2002) emphasises 
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the importance of using theory to identify and evaluate potential moderators, mediators 
and predictors of therapeutic outcome. 
Cognitive behavioural theory. 
 Cognitive behavioural theory suggests that maladaptive attitudes, beliefs, 
information processing strategies and behaviours contribute to the development and 
maintenance of symptoms of various psychiatric disorders, including depressive and 
anxiety disorders (Beck, 1964; Beck, Rush, Shaw, & Emery, 1979; D. A. Clark & Beck, 
2010). The cognitive model highlights three levels of thinking; negative automatic 
thoughts at the surface level, which can be grouped into different attitudes at the 
intermediate level, and core beliefs and schemas at the deepest level of cognition (Crits-
Christoph, Gallop, Diehl, Yin, & Gibbons, 2017). These levels of cognition influence 
each other and contribute to the maintenance of psychopathology through their impact 
on feelings and behaviour (Beck et al., 1979; D. A. Clark & Beck, 2010).  
 Cognitive theory proposes that early experiences influence the development of 
schemas and core beliefs (which can be functional or maladaptive) about the self, others 
and the world. Specific events activate certain core beliefs and dysfunctional attitudes, 
evoking negative automatic thoughts, unhelpful behaviours and unpleasant emotions, 
which interact and maintain an individual’s difficulties (Beck et al., 1979; D. A. Clark 
& Beck, 2010). The cognitive behavioural model considers unhelpful and maladaptive 
thinking patterns and behaviours as common to all psychological difficulties and 
hypothesises that cognitive processes play a key mediational role in symptom change 
during psychological therapy (Beck, 1963, 1964; D. A. Clark & Beck, 2010; Garratt, 
Ingram, Rand, & Sawalani, 2007). Cognitive behavioural therapy, therefore, aims to 
focus on these processes through modifying cognitions, where there are information 
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processing or cognitive biases, and behaviours, such as avoidance behaviour, with the 
aim of improving symptoms such as a low mood or anxiety.   
Depression. 
 In line with theoretical hypotheses, the literature exploring factors contributing 
to symptomatic change in CBT for depressive disorders has primarily focused on the 
role of cognitive processes (Lemmens et al., 2016; Lorenzo-Luaces et al., 2015; Powers, 
de Kleine, & Smits, 2017). Lorenzo-Luaces et al. (2015) suggest in their recent review 
that the current empirical literature indicates that cognitive change contributes to 
symptom change in cognitive therapy, supporting the cognitive theory of depression 
(Beck, 1963, 1964). Furthermore, in a recent systematic review exploring the 
mechanisms of change in psychotherapy for depression, Lemmens et al. (2016) 
conclude that dysfunctional attitudes and negative automatic thoughts were associated 
with symptom change in the majority of studies investigating CBT and suggest that 
these processes warrant further investigation.  
 Research also highlights the role cognitive processes play in moderating 
treatment outcomes; lower levels of pre-treatment dysfunctional attitudes have been 
shown to predict improved response to treatment and lower levels of depressive 
symptom severity following CBT (Jacobs et al., 2009; Sotsky et al., 1991). Increased 
levels of pre-treatment negative automatic thoughts also predict a poorer response to 
CBT and schema therapy (Carter et al., 2018). However, other studies have failed to 
replicate this association between cognitive predictors and therapy outcomes (Fournier 
et al., 2009) or have suggested that it is the type of belief that is important. For example, 
Blatt, Quinlan, Pilkonis, and Shea (1995) found that introjective perfectionism beliefs, 
but not interpersonally oriented need for approval beliefs, predicted outcomes 
91 
 
following treatment for depression, where higher levels of pre-treatment perfectionist 
beliefs predicted increased levels of depression symptom severity and more impaired 
adjustment at post-treatment.  
 Others have argued that there is limited evidence for the role of cognitive 
processes as a mechanism predicting or underlying treatment outcomes, questioned the 
effectiveness of cognitive change procedures in bringing about symptom change 
(Longmore & Worrell, 2007) and suggested that there is limited need to include 
cognitive components in therapy (Richards et al., 2016). However, it has also been 
suggested that change mechanisms may still be cognitive, even when using non-
cognitive therapeutic procedures (Hofmann, 2008).  
Anxiety disorders. 
 Models of anxiety-related disorders place differing emphases on the role of 
cognition in the development and maintenance of psychopathology and in 
understanding factors predicting and underlying therapeutic outcomes. Some models 
focus on physiological processes, learning and behaviour (Barlow, 2002; Ledoux, 
1989; Mowrer, 1939, 1960) and see the development and maintenance of anxiety-
related disorders as involving limited cognitive mediation. However, other models 
highlight a more central role for thoughts and beliefs in the development and 
maintenance of psychopathology (D. A. Clark & Beck, 2010); for example Clark’s 
model of panic disorder (1986), models of social anxiety disorder (D. M. Clark & 
Wells, 1995), OCD (Salkovskis, 1985, 1989), PTSD (Ehlers & Clark, 2000; LoSavio, 
Dillon, & Resick, 2017), and the metacognitive and intolerance of uncertainty models 
of GAD (Dugas, Freeston, & Ladouceur, 1997; Dugas, Gagnon, Ladouceur, & 
Freeston, 1998; Wells, 1995). More recently, there has been an emphasis on both 
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behavioural and physiological responses and cognitive processes in understanding the 
development and maintenance of anxiety-related disorders (LeDoux & Pine, 2016). 
 In line with these models, there are both behavioural and cognitive perspectives 
in understanding potential predictors of outcome and mechanisms of change in CBT 
for anxiety-related disorders. Behavioural perspectives highlight fear extinction as a 
mechanism of therapeutic change (Powers et al., 2017) and cognitive perspectives 
include conscious (e.g., maladaptive thoughts and beliefs) and unconscious (e.g., 
attentional biases) processes (Powers et al., 2017). Cognitive models of anxiety suggest 
that reduction in symptom severity is associated with and preceded by change in 
maladaptive thoughts and beliefs and that greater levels of maladaptive thoughts and 
beliefs contribute to increased symptom severity (D. A. Clark & Beck, 2010).  
 There is currently a limited evidence base investigating the role of cognitive 
factors in predicting treatment outcomes in anxiety-related disorders and no collective 
agreement about the predictive utility of cognitive factors in CBT for anxiety disorders. 
For example, a recent systematic review examining treatment moderators for anxiety 
disorders, OCD and PTSD identified only four studies (of the 24 included in the review) 
that examined cognitive moderators (Schneider et al., 2015). These studies focused on 
cognitive misappraisals and perceived control; however, it was determined that limited 
conclusions could be drawn from the current literature due to the heterogeneity of 
findings (Schneider et al., 2015). In addition, Knopp et al. (2013) highlighted that 
psychological predictors have received relatively little attention in empirical research, 
with studies often focusing on factors such as demographic or symptom-specific 
variables.  
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 Results from studies focusing on specific disorders are also variable. For 
example, a systematic review focusing on OCD concluded that there is limited evidence 
for an association between OCD-related beliefs and therapeutic outcomes in CBT when 
examining beliefs as a predictor of outcome (Knopp et al., 2013). However, other 
studies have highlighted that specific pre-treatment beliefs predict therapy outcomes; 
Kyrios et al. (2015) demonstrated that pre-treatment perfectionism and intolerance of 
uncertainty beliefs were a significant predictor of OCD symptom severity at post-
treatment where lower levels of perfectionism and intolerance of uncertainty beliefs 
predicted higher levels of post-treatment OCD symptom severity. Steketee, Siev, 
Yovel, Lit, and Wilhelm (2018) found a similar pattern of results where stronger 
responsibility/threat and importance/control of thoughts beliefs predicted clinical 
improvement.  
 However, similar to studies of depression, the opposite pattern has been 
demonstrated in panic disorder; stronger dysfunctional cognitions at pre-treatment 
predicted poorer outcomes in CBT (Dow et al., 2007b) and lower levels of pre-
treatment catastrophic cognitions have been associated with greater improvement in 
cognitive therapy (Meuret, Hofmann, & Rosenfield, 2010). Although, a systematic 
review of predictors and moderators of outcomes in CBT for panic disorder did not 
identify any studies that evaluated the predictive role of beliefs on treatment outcome 
(Porter & Chambless, 2015). Maladaptive beliefs have also been shown to be a 
significant predictor of change in social anxiety symptom severity in CBT (Boden et 
al., 2012; Gregory, Wong, Marker, & Peters, 2018). In PTSD, more severe trauma 
related cognitions at pre-treatment have been shown to predict worse outcomes in 
prolonged exposure therapy plus cognitive restructuring (Moser, Cahill, & Foa, 2010). 
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These findings have been replicated, however only in a delayed (following a period of 
time on a wait-list) not immediate, treatment condition (Crockett, 2015). The delayed 
treatment condition is likely to have been a more self-selected group in this study as 
there was significant attrition in this condition and those who dropped out had 
significantly higher levels of dissociation and suppression scores than those who went 
on to engage in treatment (Crockett, 2015). Psychological mediators in CBT for GAD 
are outlined in the systematic review (pages 18-83), however no studies were identified 
that examined the predictive role of cognitive processes, such as attitudes and beliefs, 
in CBT outcomes for GAD.  
Current study. 
 This study aimed to examine cognitive predictors, specifically anxiety and 
depression related attitudes and beliefs, of treatment outcomes in CBT for depression 
and anxiety disorders. The study was designed to build on theoretical principles and the 
existing evidence base and to examine predictors of outcome in a pragmatic context of 
Improving Access to Psychological Therapies (IAPT) services. IAPT services are 
primary care mental health services across England providing low and high intensity 
psychotherapeutic interventions for people with mild to moderate depressive and 
anxiety disorders. This study was also designed to contribute to the growing evidence 
base around personalised medicine, which aims to identify variables that predict 
differential responses to treatment (DeRubeis et al., 2014; Huibers et al., 2015). 
 Decisions with services, allocation of resources and client pathways through 
services are often not made in ways that draws on the evidence base concerning 
predictors of outcome. Furthermore, there is scope for improvement in recovery rates 
in routine clinical practice; in the 2016-2017 financial year, 49.3% of people who 
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completed a course of treatment at an IAPT service in England were considered as 
moved to recovery following treatment (NHS Digital, 2017). Individuals were defined 
as recovered if their scores on outcome measures for either depression or anxiety were 
above the clinical threshold before treatment and below the clinical threshold for both 
depression and anxiety at the end of treatment. For the 2015-2016 year, recovery rates 
for high intensity CBT were 49.0% for individuals with a primary presenting problem 
of anxiety and 45.9% for individuals with a primary presenting problem of depression 
(CBT-specific outcomes were not reported for the 2016-2017 year; NHS Digital, 
2016b), suggesting that there is scope to improve recovery rates. In addition, there have 
been criticisms that findings from larger clinical trials have limited applicability in 
routine clinical practice, primarily due to strict inclusion criteria limiting ecological 
validity and implementation in routine clinical practice (McMain et al., 2015). This 
study therefore took place in the context of routine clinical practice with the aim of 
increasing clinical relevance of research findings and facilitating implementation of 
research into clinical practice. In addition, there remains limited empirical evidence 
understanding the predictive role of cognitive variables on treatment outcomes, 
particularly in anxiety disorders.  
The evidence base for cognitive predictors of outcome in CBT for anxiety 
disorders is mixed, however findings have been more consistent in studies of 
depression. Taking these findings into account, it is expected that:  
1. there will be a significant relationship between pre-treatment 
depression-related attitudes and beliefs and post-treatment outcomes, 
where greater levels of pre-treatment maladaptive beliefs predict poorer 
outcomes in CBT. 
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2. there will be a significant relationship between pre-treatment anxiety-
related attitudes and beliefs and post-treatment outcomes, where greater 
levels of pre-treatment maladaptive beliefs predict poorer outcomes in 
CBT. 
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Method 
Participants. 
Data were collected from two IAPT services in London. From one service, data 
were collected in 2017-2018 and information about both depression and anxiety related 
attitudes and beliefs was gathered (Service 1). Archival data were used from the second 
service, this was collected in 2013-2014 and examined anxiety-related attitudes and 
beliefs only (Service 2).  
Participants were those who were attending for high intensity CBT. The high 
intensity therapy pathway in IAPT services is for people with moderate to severe 
depression and/or anxiety. Criteria for accepting a referral into IAPT services include a 
primary presenting problem of depression, mixed anxiety and depression (such as 
difficulties with low self-esteem), anxiety disorders (defined as PTSD, OCD, Body 
Dysmorphic Disorder, GAD, specific phobias, health anxiety, social anxiety and panic 
disorder) or impulse control disorders (such as Trichotillomania or skin picking). 
Exclusion criteria for accepting referrals are if the primary presenting problem is 
bipolar affective disorder, psychotic symptoms or a risk of psychotic relapse, deliberate 
self-harm or suicidal behaviour that is frequent and/or life threatening, dependence on 
substances (if the individual is using substances to the extent that this impairs their 
ability to think and/or function), a personality disorder, Complex PTSD resulting from 
multiple incidents, significant learning difficulties better supported by specialist 
services, an eating disorder, psychosexual problems that are not related to anxiety or 
depression, anger that is unrelated to a common mental health problem or if there is 
also a significant forensic history. 
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Data were available from a total of 141 individuals; 51 from Service 1 and 90 
from Service 2. Participants were aged between 19 and 89 years and the mean age was 
36.99 years (SD = 13.57). The majority of participants were female (68.79%) and white 
British (56.03%).  
Power analysis. 
A power calculation based on an effect size of .085, α = .05, power = .80 and 
two predictors indicated that 117 participants would be required. It was anticipated that 
it would be unlikely to detect a large effect size (.35; Cohen, 1992), particularly given 
that the predictive effects of attitudes and beliefs were being estimated beyond pre-
treatment symptoms levels (see ‘data analysis’ section below). The anticipated effect 
size was therefore estimated to be between a small (.02; Cohen, 1992) and medium 
(.15; Cohen, 1992) effect size and set at .085. 
Measures. 
Predictor variables. 
Measures used to assess attitudes and beliefs were the Dysfunctional Attitudes 
Scale short form (DAS-SF; Beevers, Strong, Meyer, Pilkonis, & Miller, 2007) and a 
shortened version of the Anxiety Attitude and Beliefs Scale-2 (AABS-2; Brown, 
Hawkes, Cooper, Jonsdottir, & Tata, 2015), the AABS-18. 
Dysfunctional Attitudes Scale. 
The DAS-SF is a nine-item self-report questionnaire designed to measure stable 
and enduring maladaptive beliefs associated with depression, in accordance with 
cognitive theory. Individuals are asked to rate on a 4-point Likert scale from 1 (totally 
disagree) to 4 (totally agree) how well each statement describes their attitude. Scores 
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range from 9-36 with higher scores indicating more maladaptive beliefs. The DAS-SF 
1 was used for this study, which is reported to have good internal consistency (α = .84) 
and is sensitive to change over therapy (Beevers et al., 2007). This is reported to have 
good concurrent, convergent and predictive validity and is said to provide a valid and 
accurate assessment of dysfunctional attitudes in people with depression (Beevers et 
al., 2007). The DAS-SF has two subscales; perfectionism and need for approval. 
The Anxiety Attitudes and Beliefs Scale.  
 The AABS-18 is an 18-item self-report scale measuring enduring maladaptive 
beliefs related to anxiety disorders. Individuals are asked to rate on a 4-point Likert 
scale from 1 (totally disagree) to 4 (totally agree) how much they agree with a series of 
different beliefs. Scores range from 18-72 with higher scores indicating more 
maladaptive beliefs. Validity and reliability are not reported for the AABS-18; 
however, the AABS-2 is reported to be a valid measure of attitudes and beliefs 
associated with anxiety disorders (Brown et al., 2015). The AABS-2 is reported to have 
good internal consistency (α = .87) and discriminant validity (Chaw, Oei, & Lai, 2014). 
There is a strong positive correlation between the AABS-2 and AABS-18 (r = .98). The 
AABS-18 has seven subscales; body vigilance, thought manifestation, risk avoidance, 
anticipation, evaluation sensitivity, anxiety-based reasoning and catastrophising. 
Clinical Outcomes. 
Symptoms of depression.  
The Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 
2001) was used to measure symptoms of depression. This is a nine-item self-report 
questionnaire. Individuals are asked to rate on a 4-point Likert scale from 0 (not at all) 
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to 3 (nearly every day) how often they experience particular symptoms. Scores range 
from 0-27 with higher scores indicating increased severity of depression symptoms. 
The PHQ-9 has been validated in primary care populations (Kroenke, Spitzer, 
Williams, & Löwe, 2010) and is routinely used in IAPT services across England. It is 
reported to be a valid measure of depression severity and has adequate sensitivity (88%) 
and specificity (88%) for the detection of major depressive disorder using a cut-off 
score of ≥ 10 (Kroenke et al., 2001). The PHQ-9 is reported to have good internal 
consistency (α = .89) and test-retest reliability (r = 0.84; Kroenke et al., 2001) and is 
sensitive to change over treatment (Cameron, Crawford, Lawton, & Reid, 2008). 
Symptoms of anxiety disorders.  
The Generalised Anxiety Disorder-7 (GAD-7) questionnaire (Spitzer, Kroenke, 
Williams, & Löwe, 2006) was used to measure anxiety symptoms. This is a seven-item 
self-report questionnaire measuring symptoms of generalised anxiety disorder. 
Individuals are asked to rate on a 4-point Likert scale from 0 (not at all) to 3 (nearly 
every day) how often they experience particular symptoms. Scores range from 0-21 
with higher scores indicating increased severity of anxiety symptoms. The GAD-7 is 
routinely used in IAPT services and has adequate sensitivity (83%) and specificity 
(84%) for the detection of generalised anxiety disorder using a cut-off score of ≥ 8 
(Plummer, Manea, Trepel, & McMillan, 2016). The GAD-7 has been shown to be a 
valid and reliable screening tool for a number of anxiety disorders including generalised 
anxiety disorder, panic disorder and social anxiety disorder (Kroenke, Spitzer, 
Williams, Monahan, & Lowe, 2007). The GAD-7 is reported to have good internal 
consistency (α = .85; Hinz et al., 2017) and is sensitive to change over therapy (Beard 
& Bjorgvinsson, 2014). 
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Caseness.  
Caseness is the term used in IAPT services to define a clinical case of anxiety 
or depression. Someone is said to be in caseness if their score is ≥ 10 on the PHQ-9 or 
≥ 8 on the GAD-7 (NHS Digital, 2016a). 
Clinically significant improvement.  
Change from pre- to post-treatment is deemed to be a clinically significant 
improvement (CSI) if pre-treatment scores are considered to be in caseness and post-
treatment scores no longer meet the criteria for caseness (NHS England, 2017). 
Reliable improvement.  
The reliable change index (RCI) specifies the amount of change an individual 
should show on a psychometric outcome measure between two time points for a change 
to be deemed reliable and beyond that which could be due to measurement error 
(Jacobson & Truax, 1991). The RCI is 6 points for the PHQ-9 and 4 points for the 
GAD-7 (NHS England, 2017); if an individual’s score changes by ≥ 6 on the PHQ-9 or 
≥ 4 on the GAD-7, this can be deemed to be a statistically reliable improvement (RI). 
Reliable and clinically significant improvement.  
A person is deemed to have made a reliable and clinically significant 
improvement (RCSI) when they meet the criteria for both clinically significant 
improvement and reliable improvement (Delgadillo et al., 2014; NHS Digital, 2016a).  
Caseness, CSI, RI and RCSI were included as outcome variables in addition to 
PHQ-9 and GAD-7 scores to provide additional ways of operationalising change and 
treatment outcome. These are routinely used as outcome variables in IAPT services 
therefore use of these variables aimed to enhance the applicability of this research to 
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routine clinical practice. It has also been suggested that using clinically significant 
change as an outcome variable may lead to more consistent findings (Kyrios et al., 
2015). 
Procedures. 
As part of routine clinical practice in IAPT services, individuals complete the 
PHQ-9 and GAD-7, among other outcome measures, at assessment and every therapy 
session. In Service 1, individuals attending for an assessment for high intensity therapy 
were also given the DAS-SF and AABS-18 to complete. In Service, 2 individuals were 
given the AABS-2 at their assessment appointment. During this appointment 
participants were given an information sheet about this study and therapists took verbal 
consent to share data for research purposes. 
Demographic information, type of therapy, number of therapy sessions and data 
from the PHQ-9 and GAD-7 at pre- and post-treatment were gathered from client’s 
clinical notes. All therapists were trainee or qualified high intensity CBT therapists or 
trainee or qualified clinical or counselling psychologists. 
Ethical approval. 
NHS ethical approval was granted for this research; favourable ethical opinion 
was granted by the South Central – Berkshire B Research Ethics Committee (REC) for 
Service 1 and by the London – Queen Square REC for Service 2. Approval was also 
granted by the NHS Health Research Authority and Research and Development for 
study sites. Ethical approval was granted by Royal Holloway University of London 
through the self-certification process as NHS ethical approval had been granted. 
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Data analytic strategy. 
Hypotheses were tested using regression analyses; hierarchical linear regression 
analyses were completed where the outcome variable was continuous and logistic 
regression analyses were completed where the outcome variable was categorical. 
Pearson’s correlations were used to explore data prior to regression analyses.  
Hierarchical linear regression analyses were carried out to evaluate the extent 
to which pre-treatment attitudes and beliefs predicted post-treatment symptoms of 
depression and anxiety, as measured by the PHQ-9 and GAD-7, respectively. Pre-
treatment symptom level has been shown to predict post-treatment symptoms (Arch & 
Ayers, 2013; Dow et al., 2007b; Eskildsen, Hougaard, & Rosenberg, 2010; Kyrios et 
al., 2015; Vittengl et al., 2016), therefore pre-treatment symptom scores were entered 
at step 1 and DAS-SF or AABS-18 data were entered at step 2. This allowed 
examination of the predictive role of attitudes and beliefs on post-treatment symptoms, 
over and above pre-treatment symptom levels. 
Logistic regression analyses were carried out to evaluate whether pre-treatment 
attitudes and beliefs predicted post-treatment caseness, clinically significant 
improvement, reliable improvement and reliable and clinically significant 
improvement. As in the hierarchical linear regression analyses, pre-treatment symptom 
scores were entered at step 1 and DAS-SF or AABS-18 data were entered at step 2. 
Data were analysed using IBM Statistical Package for Social Sciences (SPSS) 
version 21. 
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Data screening. 
Prior to statistical analysis data were examined for input errors, missing values, 
normality, and violations of assumptions of regression analyses. Little’s Missing 
Completely at Random (MCAR) test (Little, 1988) was used to identify whether data 
were MCAR. Normality was investigated by examining z-scores for skewness and 
kurtosis. Data were considered to be normally distributed if z-scores were less than 2.58 
(p > .01). Although normal distribution of variables is not a specified assumption for 
regression analyses, Tabachnick and Fidel (2007) recommend screening for normality.   
Pearson’s correlations between predictor variables were used to assess 
multicollinearity alongside variance inflation factors (VIF); correlations among 
predictor variables should be less than .90 (Tabachnick & Fidel, 2007) and the VIF 
should be less than 10 (Myers, 1990). Unless otherwise stated, it should be assumed 
that this and other main assumptions of regression analyses were not violated.  
The internal consistency reliability of the DAS-SF and AABS-18 measures 
were also examined.  
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Results 
Demographic information and descriptive statistics. 
In Service 1, a total of 51 patients participated in the study.  In Service 2, data 
from 90 patients were available. There were therefore 51 participants for whom DAS-
SF data were available and 139 for whom AABS-18 data were available (two 
participants in Service 1 did not complete the AABS-18). Data were included from 
people who received high intensity CBT and had at least two time points for PHQ-9 
and GAD-7 data. Demographic information from both samples is included in Table 1.  
 Due to timing restrictions in the completion of this project, not all participants 
in Service 1 had completed therapy when results were analysed; 23 (45% of those in 
Service 1) had not yet completed therapy. Completion of therapy was defined as ending 
of the course of individual high intensity CBT. Of those who had not completed 
therapy, treatment was ongoing and 65% had completed over 10 sessions. For those 
who had not completed therapy, PHQ-9 and GAD-7 data were collected from their most 
recent session for the Time 2 (post-treatment) assessment. 
 
Table 1. 
Demographic data for the two study samples 
 Sample (DAS-SF) Sample (AABS-18) 
Variable n = 51 n = 139 
Age Mean (SD) 33.61 (11.01) 37.20 (13.55) 
Gender % 
 Female 
 Male 
 
73.55 
27.45 
 
68.35 
31.65 
Ethnicity % 
 White (British) 
 White (any other) 
 
64.71 
15.69 
 
56.83 
18.71 
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 Mixed (White and Black Caribbean) 
 Black Caribbean 
 Black African 
 Mixed (any other) 
 Indian 
 Pakistani 
 Chinese 
 Other 
 Not stated 
5.88 
3.92 
3.92 
1.96 
0.00 
0.00 
0.00 
1.96 
1.96 
2.16 
2.88 
3.60 
2.16 
1.44 
1.44 
2.16 
3.60 
5.76 
Primary diagnosis % 
 Depressive episode 
 Generalised anxiety disorder 
 Social anxiety disorder 
 Recurrent depressive disorder 
 Obsessive compulsive disorder 
 Post-traumatic stress disorder 
 Panic disorder 
 Health anxiety 
 Agoraphobia 
 Mixed anxiety and depressive disorder 
 Mental disorder NOS 
 Hypochondriacal disorder 
 Not stated 
 
25.49 
17.65 
15.69 
13.73 
7.84 
5.88 
3.92 
3.92 
1.96 
0.00 
1.96 
0.00 
1.96 
 
24.46 
15.11 
6.47 
16.55 
2.88 
4.32 
4.32 
1.44 
1.44 
5.76 
2.88 
1.44 
13.67 
Number of therapy sessions Mean (SD) 9 (4.38) 8 (5.62) 
Note. SD = standard deviation. 
 
Means and standard deviations for outcome measures for the two time points 
are presented in Table 2.  
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Table 2. 
Means and standard deviations for the outcome measures 
 DAS-SF sample (n = 51) AABS-18 sample (n = 139) 
Outcome Pre-treatment Post-treatment Pre-treatment Post-treatment 
DAS-SF Mean (SD) 23.96 (5.02) - - - 
AABS-2 Mean (SD) - - 49.52 (9.48) - 
PHQ-9 Mean (SD) 10.63 (5.84) 6.57 (5.52) 13.14 (6.11) 8.96 (6.50) 
GAD-7 Mean (SD) 10.75 (4.49) 6.51 (4.84) 11.96 (5.16) 8.15 (5.71) 
PHQ-9 Caseness % 50.98 19.61 67.63 38.13 
GAD-7 Caseness % 76.47 31.37 78.42 43.88 
PHQ-9 CSI % - 61.54 - 45.74 
GAD-7 CSI % - 64.10 - 49.54 
PHQ-9 RI % - 29.41 - 33.09 
GAD-7 RI % - 66.67 - 53.96 
PHQ-9 RCSI % - 25.49 - 25.18 
GAD-7 RCSI % - 47.06 - 35.25 
Note. SD = Standard Deviation; CSI = Clinically Significant Improvement; RI = 
Reliable Improvement; RCSI = Reliable and Clinically Significant Improvement.  
Data screening. 
Six participants missed a small number of items and there were no variables 
with 5% or more missing values. Using Little’s MCAR test (Little, 1988), it was 
established that data were MCAR. Mean substitution was therefore used to impute 
missing values (Tabachnick & Fidel, 2007). 
In the DAS-SF sample, Time 2 data for the PHQ-9 and GAD-7 were positively 
skewed (PHQ-9: z = 3.58, p <.01; GAD-7: z = 3.43, p <.01). Square root transformations 
108 
 
were carried out, which resulted in the data being normally distributed (PHQ-9: z = -
0.36, p >.01; GAD-7: z = -0.62, p >.01). In the AABS-18 sample, Time 2 data for the 
PHQ-9 and GAD-7 were also positively skewed (PHQ-9: z = 3.57, p <.01; GAD-7: z = 
3.49, p <.01). Square root transformations were carried out, which resulted in the data 
being normally distributed (PHQ-9: z = -1.12, p >.01; GAD-7: z = -1.14, p >.01).  
The assumption of homoscedasticity was violated in the non-transformed 
samples, however transforming the data corrected for this assumption. 
Questionnaire reliability. 
 Both the DAS-SF and AABS-18 were shown to have good internal consistency 
(α = .85 and α = .88, respectively). Individual data from each item of the PHQ-9 and 
GAD-7 were not available from Service 2, therefore internal consistency of the PHQ-9 
and GAD-7 could not be established. However, these questionnaires are well validated 
in primary care populations and routinely used in IAPT services, as outlined above. 
 Correlations. 
 To provide an initial understanding of the relationship between DAS-SF, 
AABS-18, PHQ-9 and GAD-7 data and to assess multicollinearity, Pearson’s 
correlations were conducted between each of these variables, see Table 3. To control 
for multiple testing and reduce the chance of a Type I error, a Bonferroni correction 
was applied and the criterion for significance was set at p = .003. 
 There were significant positive correlations between pre-treatment depression 
symptoms and pre-treatment anxiety related attitudes and beliefs (r(137) = .25, p = 
.003), post-treatment depression symptoms (r(137) = .55, p < .001), pre-treatment 
anxiety symptoms (r(137) = .68, p < .001) and post-treatment anxiety symptoms (r(137) 
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= .44, p < .001). There were significant positive correlations between pre-treatment 
anxiety symptoms and anxiety related attitudes and beliefs (r(137) = .41, p < .001), pre-
treatment depression symptoms (r(137) = .68, p < .001), post treatment depression 
symptoms (r(137) = .42, p < .001) and post-treatment anxiety symptoms (r(137) = .47, 
p < .001).   
Table 3. 
Correlation matrix showing Pearson’s r for DAS-SF, AABS-18, PHQ-9 and GAD-7 
data.  
Variable DAS-SF AABS-18 T1 PHQ-9 T2 PHQ-9 T1 GAD-7 T2 GAD-7 
DAS -      
AABS .407** -     
T1 PHQ-9 .154 .254** -    
T2 PHQ-9 .049 .100 .547*** -   
T1 GAD-7 .307* .410*** .681*** .420*** -  
T2 GAD-7 .159 .228** .443*** .843*** .470*** - 
Note. ***p < .001; **p < .01; *p < .05 
 
Predicting symptom severity. 
Depression related attitudes and beliefs 
Anxiety symptoms. 
At step 1, pre-treatment anxiety symptoms explained a significant amount of 
variance in post-treatment anxiety symptom severity (F(1,49) = 7.10, p = .010; R2 = 
.13, adjusted R2 = .11). At step 2, attitudes and beliefs did not contribute to a significant 
increase in variance in post-treatment anxiety symptoms (p = .699). In the final 
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equation, only pre-treatment anxiety symptom severity made a significant unique 
contribution to explaining post-treatment anxiety symptom severity (t(48) = 2.40, p = 
.02, β = .34), see Table 4. 
Depression symptoms. 
At step 1, pre-treatment depression symptoms explained a significant amount 
of variance in post-treatment depression symptom severity (F(1,49) = 18.09, p < .001; 
R2 = .27, adjusted R2 = .26). At step 2, attitudes and beliefs did not contribute to a 
significant increase in variance in post-treatment depression symptom severity (p = 
.801). In the final equation, only pre-treatment depression symptom severity made a 
significant unique contribution to explaining post-treatment symptom severity (t(48) = 
4.20, p < .001, β = .52), see Table 4.  
Anxiety related attitudes and beliefs 
Anxiety symptoms. 
At step 1, pre-treatment anxiety symptoms explained a significant amount of 
variance in post-treatment anxiety symptom severity (F(1,137) = 38.57, p < .001; R2 = 
.22, adjusted R2 = .21). At step 2, attitudes and beliefs did not contribute to a significant 
increase in variance in post-treatment anxiety symptoms (p = .608). In the final 
equation, only pre-treatment anxiety symptom severity made a significant unique 
contribution to explaining post-treatment symptom severity (t(136) = 5.44, p < .001, β 
= .45), see Table 4.  
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Depression symptoms. 
At step 1, pre-treatment depression symptoms explained a significant amount 
of variance in post-treatment depression symptom severity (F(1,137) = 58.04, p < .001; 
R2 = .30, adjusted R2 = .29). At step 2, attitudes and beliefs did not contribute to a 
significant increase in variance in post-treatment depression symptoms (p = .574). In 
the final equation, only pre-treatment depression symptom severity made a significant 
unique contribution to explaining post-treatment symptom severity (t(136) = 7.49, p < 
.001, β = .56), see Table 4. 
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Table 4. 
Summary of hierarchical regression analyses predicting post-treatment symptom severity 
Variable B (SE) Standardised β t p R2 change 
Predictor variable DAS-SF (n = 51)    
DV: post-treatment GAD-7 score 
Step 1 
 Pre-treatment GAD-7 
Step 2 
 Pre-treatment GAD-7 
 Pre-treatment DAS-SF 
 
 
0.51 (0.19) 
 
0.48 (0.20) 
0.01 (0.03) 
 
 
.36 
 
.34 
.05 
 
 
2.67 
 
2.40 
0.39 
 
 
.010* 
 
.021* 
.699 
 
 
.127 
 
 
.003 
DV: post-treatment PHQ-9 score 
Step 1 
 Pre-treatment PHQ-9 
Step 2 
 Pre-treatment PHQ-9 
 Pre-treatment DAS-SF 
 
 
0.65 (0.15) 
 
0.66 (0.16) 
-0.01 (0.03) 
 
 
.52 
 
.52 
-.03 
 
 
4.25 
 
4.20 
-0.25 
 
 
.000*** 
 
.000*** 
.801 
 
 
.270 
 
 
.001 
Predictor variable: AABS-18 (n = 139)     
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Variable B (SE) Standardised β t p R2 change 
DV: post-treatment GAD-7 score 
Step 1 
 Pre-treatment GAD-7 
Step 2 
 Pre-treatment GAD-7 
 Pre-treatment AABS-18 
 
 
0.62 (0.10) 
 
0.60 (0.11) 
0.01 (0.01) 
 
 
.47 
 
.45 
.04 
 
 
6.21 
 
5.44 
0.51 
 
 
.000*** 
 
.000*** 
.608 
 
 
.220 
 
 
.002 
DV: post-treatment PHQ-9 score 
Step 1 
 Pre-treatment PHQ-9 
Step 2 
 Pre-treatment PHQ-9 
 Pre-treatment AABS-18 
 
 
0.72 (0.09) 
 
0.73 (0.10) 
-0.01 (0.01) 
 
 
.55 
 
.56 
-.04 
 
 
7.62 
 
7.49 
-0.56 
 
 
.000*** 
 
.000*** 
.574 
 
 
.298 
 
 
.002 
Note. DV = dependent variable. ***p < .001; **p < .01; *p < .05 
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Predicting caseness. 
Depression related attitudes and beliefs 
Anxiety symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 14.05, p = .001), indicating that the predictors together 
reliably predicted caseness. This model correctly predicted caseness status in 78.4% of 
the cases. According to the Wald criterion, the only successful predictor was pre-
treatment anxiety symptom severity (χ2(1) = 9.43, p = .002, Exp(B) = .72), where higher 
levels of pre-treatment symptom severity meant that participants were more likely to 
be in caseness at post-treatment. Attitudes and beliefs were not independently 
predictive of caseness (p = .301), see Table 5. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of depression related attitudes and beliefs, after controlling 
for pre-treatment anxiety symptom severity (χ2(1) = 1.11, p = .292). 
Depression symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 22.38, p < .001), indicating that the predictors together 
reliably predicted caseness. This model correctly classified caseness status in 86.3% of 
the cases. According to the Wald criterion, the only successful predictor was pre-
treatment depression symptom severity (χ2(1) = 9.92, p = .002, Exp(B) = .67), where 
higher levels of pre-treatment symptom severity meant that participants were more 
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likely to be in caseness at post-treatment. Attitudes and beliefs were not independently 
predictive of caseness (p = .891), see Table 5. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of depression related attitudes and beliefs, after controlling 
for pre-treatment depression symptom severity (χ2(1) = .02, p = .891). 
Anxiety related attitudes and beliefs 
Anxiety symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 34.99, p < .001), indicating that the predictors together 
reliably predicted caseness. This model correctly predicted caseness status in 71.9% of 
the cases. According to the Wald criterion, only pre-treatment anxiety symptom 
severity significantly predicted post-treatment caseness (χ2(1) = 20.75, p < .000, Exp(B) 
= .81), where higher levels of pre-treatment symptom severity meant that participants 
were more likely to be in caseness at post-treatment. Attitudes and beliefs did not add 
significant predictive power to the model (p = .256), see Table 5.  
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of anxiety related attitudes and beliefs, after controlling for 
pre-treatment anxiety symptom severity (χ2(1) = 1.30, p = .255). 
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Depression symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 46.90, p < .001), indicating that the predictors together 
reliably predicted caseness. This model correctly classified caseness status in 76.3% of 
the cases. According to the Wald criterion, only pre-treatment depression symptom 
severity significantly predicted post-treatment caseness (χ2(1) = 29.15, p < .001, Exp(B) 
= .79), where higher levels of pre-treatment symptom severity meant that participants 
were more likely to be in caseness at post-treatment. Attitudes and beliefs were not 
independently predictive of caseness (p = .552), see Table 5.  
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of anxiety related attitudes and beliefs, after controlling for 
pre-treatment depression symptom severity (χ2(1) = .35, p = .552). 
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Table 5. 
Summary of logistic regression analyses predicting post-treatment caseness 
  Wald Chi-
Square 
 Odds Ratio 
(ExpB)  
95% CI for Odds Ratio 
Variable B (SE) p Lower Upper 
Predictor variable DAS-SF (n = 51) 
DV: post-treatment GAD-7 caseness 
Step 1 
 Pre-treatment GAD-7 
Step 2 
 Pre-treatment GAD-7 
 Pre-treatment DAS-SF 
 
 
-0.28 (0.09) 
 
-0.33 (0.11) 
0.08 (0.08) 
 
 
9.51 
 
9.43 
1.07 
 
 
.002** 
 
.002** 
.301 
 
 
0.76 
 
0.72 
1.09 
 
 
0.63 
 
0.59 
0.93 
 
 
0.90 
 
0.89 
1.27 
DV: post-treatment PHQ-9 caseness 
Step 1 
 Pre-treatment PHQ-9 
Step 2 
 Pre-treatment PHQ-9 
 Pre-treatment DAS-SF 
 
 
-0.41 (0.13) 
 
-0.41 (0.13) 
0.01 (0.09) 
 
 
9.83 
 
9.92 
0.02 
 
 
.002** 
 
.002** 
.891 
 
 
0.67 
 
0.67 
1.01 
 
 
0.52 
 
0.52 
0.84 
 
 
0.86 
 
0.86 
1.22 
Predictor variable: AABS-18 (n = 139) 
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  Wald Chi-
Square 
 Odds Ratio 
(ExpB)  
95% CI for Odds Ratio 
Variable B (SE) p Lower Upper 
DV: post-treatment GAD-7 caseness 
Step 1 
 Pre-treatment GAD-7 
Step 2 
 Pre-treatment GAD-7 
 Pre-treatment AABS-18 
 
 
-0.22 (0.04) 
 
-0.21 (0.05) 
-0.03 (0.02) 
 
 
25.49 
 
20.75 
1.29 
 
 
.000*** 
 
.000*** 
.256 
 
 
0.80 
 
0.81 
0.98 
 
 
0.73 
 
0.74 
0.93 
 
 
0.87 
 
0.89 
1.02 
DV: post-treatment PHQ-9 caseness 
Step 1 
 Pre-treatment PHQ-9 
Step 2 
 Pre-treatment PHQ-9 
 Pre-treatment AABS-18 
 
 
-0.24 (0.04) 
 
-0.24 (0.04) 
-0.01 (0.02) 
 
 
31.23 
 
29.15 
0.35 
 
 
.000*** 
 
.000*** 
.552 
 
 
0.79 
 
0.79 
0.99 
 
 
0.72 
 
0.73 
0.95 
 
 
0.86 
 
0.86 
1.03 
Note. DV = dependent variable, CI = confidence interval. ***p < .001; **p < .01; *p < .05 
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Predicting clinically significant improvement. 
Depression related attitudes and beliefs 
Anxiety symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 12.04, p = .002), indicating that the predictors together 
reliably predicted CSI. This model correctly predicted CSI status in 75.7% of the cases. 
The only successful predictor was pre-treatment anxiety symptom severity (χ2(1) = 
7.63, p = .006, Exp(B) = 1.53), where higher levels of pre-treatment symptom severity 
meant that participants were less likely make a clinically significant improvement. 
Attitudes and beliefs were not independently predictive of CSI (p = .258), see Table 6. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of depression related attitudes and beliefs, after controlling 
for pre-treatment anxiety symptom severity (χ2(1) = 1.37, p = .241). 
Depression symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 6.71, p = .035), indicating that the predictors together 
reliably predicted CSI. This model correctly predicted CSI status in 72.0% of the cases. 
Only pre-treatment depression symptom severity significantly predicted CSI (χ2(1) = 
4.73, p = .030, Exp(B) = 1.38), where higher levels of pre-treatment symptom severity 
meant that participants were less likely make a clinically significant improvement. 
Attitudes and beliefs were not independently predictive of CSI (p = .843), see Table 6. 
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Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of depression related attitudes and beliefs, after controlling 
for pre-treatment depression symptom severity (χ2(1) = .04, p = .843). 
Anxiety related attitudes and beliefs 
Anxiety symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 22.06, p < .001), indicating that the predictors together 
reliably predicted CSI. This model correctly predicted CSI status in 71.6% of the cases. 
The only successful predictor was pre-treatment anxiety symptom severity (χ2(1) = 
15.34, p < .001, Exp(B) = 1.28), where higher levels of pre-treatment symptom severity 
meant that participants were less likely make a clinically significant improvement. 
Attitudes and beliefs were not independently predictive of CSI (p = .506), see Table 6. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of anxiety related attitudes and beliefs, after controlling for 
pre-treatment anxiety symptom severity (χ2(1) = .44, p = .506). 
Depression symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 10.99, p = .004), indicating that the predictors together 
reliably predicted CSI. This model correctly predicted CSI status in 68.1% of the cases. 
Only pre-treatment depression symptom severity significantly predicted CSI (χ2(1) = 
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7.41, p = .007, Exp(B) = 1.17), where higher levels of pre-treatment symptom severity 
meant that participants were less likely make a clinically significant improvement. 
Attitudes and beliefs were not independently predictive of CSI (p = .257), see Table 6. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of anxiety related attitudes and beliefs, after controlling for 
pre-treatment depression symptom severity (χ2(1) = 1.30, p = .254). 
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Table 6. 
Summary of logistic regression analyses predicting clinically significant improvement 
Variable B (SE) 
Wald Chi-
Square p 
Odds Ratio 
(ExpB) 
95% CI for Odds Ratio 
Lower Upper 
Predictor variable DAS (n = 51) 
DV: GAD-7 CSI 
Step 1 
 Pre-treatment GAD-7 
Step 2 
 Pre-treatment GAD-7 
 Pre-treatment DAS 
 
 
0.35 (0.13) 
 
0.43 (0.16) 
-0.11 (0.09) 
 
 
7.62 
 
7.63 
1.28 
 
 
.006** 
 
.006** 
.258 
 
 
1.41 
 
1.53 
0.90 
 
 
1.11 
 
1.13 
0.75 
 
 
1.81 
 
2.08 
1.08 
DV: PHQ-9 CSI 
Step 1 
 Pre-treatment PHQ-9 
Step 2 
 Pre-treatment PHQ-9 
 Pre-treatment DAS 
 
 
0.32 (0.15) 
 
0.32 (0.15) 
-0.02 (0.09) 
 
 
4.70 
 
4.73 
0.04 
 
 
.030* 
 
.030* 
.843 
 
 
1.38 
 
1.38 
0.98 
 
 
1.03 
 
1.03 
0.82 
 
 
1.84 
 
1.84 
1.18 
Predictor variable: AABS (n = 139) 
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Variable B (SE) 
Wald Chi-
Square p 
Odds Ratio 
(ExpB) 
95% CI for Odds Ratio 
Lower Upper 
DV: GAD-7 CSI 
Step 1 
 Pre-treatment GAD-7 
Step 2 
 Pre-treatment GAD-7 
 Pre-treatment AABS 
 
 
0.25 (0.06) 
 
0.24 (0.06) 
0.02 (0.02) 
 
 
17.52 
 
15.34 
0.44 
 
 
.000*** 
 
.000*** 
.506 
 
 
1.29 
 
1.28 
1.02 
 
 
1.15 
 
1.13 
0.97 
 
 
1.45 
 
1.44 
1.06 
DV: PHQ-9 CSI 
Step 1 
 Pre-treatment PHQ-9 
Step 2 
 Pre-treatment PHQ-9 
 Pre-treatment AABS 
 
 
0.17 (0.06) 
 
0.16 (0.06) 
0.03 (0.02) 
 
 
8.62 
 
7.41 
1.28 
 
 
.003** 
 
.007** 
.257 
 
 
1.18 
 
1.17 
1.03 
 
 
1.06 
 
1.05 
0.98 
 
 
1.32 
 
1.31 
1.07 
Note. DV = dependent variable, CI = confidence interval, CSI = clinically significant improvement. ***p < .001; **p < .01; *p < .05 
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Predicting reliable improvement. 
Depression related attitudes and beliefs 
Anxiety symptoms. 
A test of the full model with both predictors against a constant-only model was 
not statistically significant (χ2(2) = 4.40, p = .111). This model correctly predicted RI 
status in 74.5% of the cases. Only pre-treatment anxiety symptom severity significantly 
predicted RI (χ2(1) = 3.87, p = .049, Exp(B) = .85), where higher levels of pre-treatment 
symptom severity meant that participants were less likely make a reliable improvement. 
Attitudes and beliefs were not independently predictive of RI (p = .481), see Table 7. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of depression related attitudes and beliefs, after controlling 
for pre-treatment anxiety symptom severity (χ2(1) = .50, p = .478). 
Depression symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 10.26, p = .006), indicating that the predictors together 
reliably predicted RI. This model correctly predicted RI status in only 66.7% of the 
cases. Only pre-treatment depression symptom severity significantly predicted RI (χ2(1) 
= 7.77, p = .005, Exp(B) = .84), where higher levels of pre-treatment symptom severity 
meant that participants were less likely make a reliable improvement. Attitudes and 
beliefs were not independently predictive of RI (p = .605), see Table 7. 
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Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of depression related attitudes and beliefs, after controlling 
for pre-treatment depression symptom severity (χ2(1) = .27, p = .605). 
Anxiety related attitudes and beliefs 
Anxiety symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 13.34, p = .001), indicating that the predictors together 
reliably predicted RI. This model correctly predicted RI status in only 64.0% of the 
cases. Only pre-treatment anxiety symptom severity significantly predicted RI (χ2(1) = 
12.01, p = .001, Exp(B) = .87), where higher levels of pre-treatment symptom severity 
meant that participants were less likely make a reliable improvement. Attitudes and 
beliefs were not independently predictive of RI (p = .218), see Table 7. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of anxiety related attitudes and beliefs, after controlling for 
pre-treatment anxiety symptom severity (χ2(1) = 1.56, p = .212). 
Depression symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 22.62, p < .001), indicating that the predictors together 
reliably predicted RI. This model correctly predicted RI status in only 66.2% of the 
cases. Only pre-treatment depression symptom severity significantly predicted RI (χ2(1) 
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= 18.33, p < .001, Exp(B) = .85), where higher levels of pre-treatment symptom severity 
meant that participants were less likely make a reliable improvement. Attitudes and 
beliefs were not independently predictive of RI (p = .514), see Table 7. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of anxiety related attitudes and beliefs, after controlling for 
pre-treatment depression symptom severity (χ2(1) = .43, p = .513). 
 
 
 
127 
 
Table 7. 
Summary of logistic regression analyses predicting reliable improvement 
Variable B (SE) 
Wald Chi-
Square p 
Odds Ratio 
(ExpB) 
95% CI for Odds Ratio 
Lower Upper 
Predictor variable DAS-SF (n = 51) 
DV: GAD-7 RI 
Step 1 
 Pre-treatment GAD-7 
Step 2 
 Pre-treatment GAD-7 
 Pre-treatment DAS-SF 
 
 
-0.14 (0.08) 
 
-0.16 (0.08) 
0.05 (0.07) 
 
 
3.42 
 
3.87 
0.49 
 
 
.064 
 
.049* 
.481 
 
 
0.87 
 
0.85 
1.05 
 
 
0.75 
 
0.73 
0.92 
 
 
1.01 
 
1.00 
1.20 
DV: PHQ-9 RI 
Step 1 
 Pre-treatment PHQ-9 
Step 2 
 Pre-treatment PHQ-9 
 Pre-treatment DAS-SF 
 
 
-0.18 (0.06) 
 
-0.18 (0.07) 
-0.04 (0.07) 
 
 
8.06 
 
7.77 
0.27 
 
 
.005** 
 
.005** 
.605 
 
 
0.83 
 
0.84 
0.96 
 
 
0.74 
 
0.74 
0.84 
 
 
0.95 
 
0.95 
1.11 
Predictor variable: AABS-18 (n = 139) 
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Variable B (SE) 
Wald Chi-
Square p 
Odds Ratio 
(ExpB) 
95% CI for Odds Ratio 
Lower Upper 
DV: GAD-7 RI 
Step 1 
 Pre-treatment GAD-7 
Step 2 
 Pre-treatment GAD-7 
 Pre-treatment AABS-
18 
 
 
-0.12 (0.04) 
 
-0.14 (0.04) 
0.03 (0.02) 
 
 
10.75 
 
12.01 
1.51 
 
 
.001** 
 
.001** 
.218 
 
 
0.89 
 
0.87 
1.03 
 
 
0.83 
 
0.81 
0.99 
 
 
0.95 
 
0.94 
1.07 
DV: PHQ-9 RI 
Step 1 
 Pre-treatment PHQ-9 
Step 2 
 Pre-treatment PHQ-9 
 Pre-treatment AABS-
18 
 
 
-0.15 (0.04) 
 
-0.16 (0.04) 
0.01 (0.02) 
 
 
18.31 
 
18.33 
0.43 
 
 
.000*** 
 
.000*** 
.514 
 
 
0.86 
 
0.85 
1.01 
 
 
0.80 
 
0.79 
0.97 
 
 
0.92 
 
0.92 
1.06 
Note. DV = dependent variable, CI = confidence interval, RI = reliable improvement. ***p < .001; **p < .01; *p < .05 
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Predicting reliable and clinically significant improvement. 
Depression related attitudes and beliefs 
Anxiety symptoms. 
A test of the full model with both predictors against a constant-only model was 
not statistically significant (χ2(2) = .32, p = .851). This model correctly predicted RCSI 
status in only 45.1% of the cases. Neither pre-treatment anxiety symptom severity 
significantly (p = .590) nor attitudes and beliefs (p = .730) were independently 
predictive of RCSI, see Table 8. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of depression related attitudes and beliefs, after controlling 
for pre-treatment anxiety symptom severity (χ2(1) = .12, p = .730). 
Depression symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 8.43, p = .015), indicating that the predictors together 
reliably predicted RCSI. This model correctly predicted RCSI status in 68.6% of the 
cases. Only pre-treatment depression symptom severity significantly predicted RCSI 
(χ2(1) = 6.87, p = .009, Exp(B) = .84), where higher levels of pre-treatment symptom 
severity meant that participants were less likely make a reliable and clinically 
significant improvement. Attitudes and beliefs were not independently predictive of 
RCSI (p = .890), see Table 8. 
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Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of depression related attitudes and beliefs, after controlling 
for pre-treatment depression symptom severity (χ2(1) = .02, p = .890). 
Anxiety related attitudes and beliefs 
Anxiety symptoms. 
A test of the full model with both predictors against a constant-only model was 
not statistically significant (χ2(2) = 1.64, p = .440). This model correctly predicted RCSI 
status in only 64.7% of the cases. Neither pre-treatment anxiety symptom severity 
significantly (p = .218) nor attitudes and beliefs (p = .429) were independently 
predictive of RCSI, see Table 8. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of anxiety related attitudes and beliefs, after controlling for 
anxiety symptom severity (χ2(1) = .63, p = .428). 
Depression symptoms. 
A test of the full model with both predictors against a constant-only model was 
statistically significant (χ2(2) = 9.77, p = .008), indicating that the predictors together 
reliably predicted RCSI. This model correctly predicted RCSI status in 74.1% of the 
cases. Only pre-treatment depression symptom severity significantly predicted RCSI 
(χ2(1) = 8.88, p = .003, Exp(B) = .90), where higher levels of pre-treatment symptom 
severity meant that participants were less likely make a reliable and clinically 
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significant improvement. Attitudes and beliefs were not independently predictive of 
RCSI (p = .515), see Table 8. 
Comparison of log-likelihood ratios to assess change in model fit from step 1 to 
step 2 indicated that there was no statistically significant improvement in model fit with 
the addition of the predictor of anxiety related attitudes and beliefs, after controlling for 
pre-treatment depression symptom severity (χ2(1) = .43, p = .515). 
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Table 8. 
Summary of logistic regression analyses predicting reliable and clinically significant improvement 
Variable B (SE) 
Wald Chi-
Square p 
Odds Ratio 
(ExpB) 
95% CI for Odds Ratio 
Lower Upper 
Predictor variable DAS-SF (n = 51) 
DV: GAD-7 RCSI 
Step 1 
 Pre-treatment GAD-7 
Step 2 
 Pre-treatment GAD-7 
 Pre-treatment DAS-SF 
 
 
-0.03 (0.06) 
 
-0.04 (0.07) 
0.02 (0.06) 
 
 
0.20 
 
0.29 
0.12 
 
 
.653 
 
.590 
.730 
 
 
0.97 
 
0.96 
1.02 
 
 
0.86 
 
0.85 
0.91 
 
 
1.10 
 
1.10 
1.15 
DV: PHQ-9 RCSI 
Step 1 
 Pre-treatment PHQ-9 
Step 2 
 Pre-treatment PHQ-9 
 Pre-treatment DAS-SF 
 
 
-0.17 (0.07) 
 
-0.17 (0.07) 
-0.01 (0.07) 
 
 
7.00 
 
6.87 
0.02 
 
 
.008** 
 
.009** 
.890 
 
 
0.84 
 
0.84 
0.99 
 
 
0.74 
 
0.74 
0.86 
 
 
0.96 
 
0.96 
1.14 
Predictor variable: AABS-18 (n = 139) 
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Variable B (SE) 
Wald Chi-
Square p 
Odds Ratio 
(ExpB) 
95% CI for Odds Ratio 
Lower Upper 
DV: GAD-7 RCSI 
Step 1 
 Pre-treatment GAD-7 
Step 2 
 Pre-treatment GAD-7 
 Pre-treatment AABS-18 
 
 
-0.04 (0.04) 
 
-0.05 (.04) 
0.02 (0.02) 
 
 
1.01 
 
1.52 
0.62 
 
 
.316 
 
.218 
.429 
 
 
0.97 
 
0.95 
1.02 
 
 
0.90 
 
0.89 
0.98 
 
 
1.03 
 
1.03 
1.06 
DV: PHQ-9 RCSI 
Step 1 
 Pre-treatment PHQ-9 
Step 2 
 Pre-treatment PHQ-9 
 Pre-treatment AABS-18 
 
 
-0.10 (0.04) 
 
-0.11 (0.04) 
0.01 (0.02) 
 
 
8.54 
 
8.88 
0.42 
 
 
.003** 
 
.003** 
.515 
 
 
0.90 
 
0.90 
1.10 
 
 
0.84 
 
0.84 
0.97 
 
 
0.97 
 
0.96 
1.06 
Note. DV = dependent variable, CI = confidence interval, RCSI = reliable and clinically significant improvement. ***p < .001; **p < 
.01;   *p < .05 
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Summary. 
The hypotheses that both depression and anxiety related attitudes and beliefs 
would predict outcomes in CBT were not supported. Neither depression nor anxiety 
related attitudes and beliefs significantly predicted post-treatment symptom severity, 
caseness, clinically significant improvement, reliable improvement or reliable and 
clinically significant improvement.  
Exploratory analyses: predicting symptom severity from DAS and AABS 
subscales. 
Post-hoc exploratory analyses were completed to review whether specific 
attitudes and beliefs, as measured by the DAS-SF and AABS-18 subscales, predicted 
post-treatment symptom severity.  
Correlations. 
Correlations between the subscales of the DAS-SF and AABS-18 and PHQ-9 
and GAD-7 data were reviewed, see Table 9. Due to the exploratory nature of these 
analysis, controls for multiple testing were not implemented to minimise the risk of 
Type II error. 
 There were significant positive correlations between pre-treatment depression 
symptom severity and risk avoidance (r(137) = .27, p = .001), evaluation sensitivity 
(r(137) = .25, p = .003), anxiety-based reasoning (r(137= .20, p = .016) and 
catastrophising (r(137) = .32, p < .001). There were also significant positive 
correlations between pre-treatment anxiety symptom severity and perfectionism (r(49) 
= .31, p = .029), body vigilance (r(137) = .29, p = .001), risk avoidance (r(137) = .32, 
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p < .001), anticipation (r(137) = .26, p = .002), evaluation sensitivity (r(137) = .33, p < 
.001), anxiety based reasoning (r(137) = .29, p = .001) and catastrophising (r(137) = 
.39, p < .001). A significant positive correlation was present between catastrophising 
and post-treatment depression symptom severity (r(137) = .19, p = .025). Significant 
positive correlations were also present between post-treatment anxiety symptom 
severity and body vigilance (r(137) = .26, p = .002), anxiety-based reasoning (r(137) = 
.19, p = .025), and catastrophising (r(137) = .214, p = .011). 
Table 9. 
Correlation matrix showing Pearson’s r data for DAS-SF and AABS-18 subscales and 
PHQ-9 and GAD-7 scores 
Variable 
Pre-treatment Post-treatment 
PHQ-9 GAD-7 PHQ-9 GAD-7 
DAS-SF     
 Perfectionism .151 .306* .071 .109 
 Need for approval .077 .270 .003 .177 
AABS-18     
 Body Vigilance .131 .285*** .139 .262** 
 Thought manifestation .155 .139 .061 .145 
 Risk Avoidance .271*** .316*** .048 .148 
 Anticipation .158 .264** .001 .114 
 Evaluation sensitivity .245** .327*** .092 .126 
 Anxiety-based reasoning .203* .289*** .093 .189* 
 Catastrophising .318*** .388*** .189* .214* 
Note. ***p < .001; **p < .01; *p < .05 
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Predicting post-treatment symptom severity. 
Hierarchical linear regression analyses were carried out to examine the extent 
to which subscales of the DAS-SF and AABS-18 predicted post-treatment depression 
and anxiety symptom severity. Pre-treatment symptom scores were entered at step 1 
and subscale data were entered at step 2. Due to the exploratory nature of this analysis, 
controls for multiple testing were not implemented to minimise the risk of Type II error. 
Pre-treatment symptom severity significantly predicted post-treatment 
symptom severity for all subscales. No subscales of the DAS-SF or AABS-18 
significantly predicted post-treatment depression or anxiety symptom severity. A trend 
towards significance was observed for the ‘body vigilance’ subscale of the AABS-18 
when predicting post-treatment anxiety symptom severity. Pre-treatment anxiety 
symptoms explained a significant amount of variance in post-treatment anxiety 
symptom severity (F(1,137) = 38.57, p < .001; R2 = .22, adjusted R2 = .21). At step 2, 
AABS-18 body vigilance contributed an increase in variance explained from 22.0% to 
23.7%, adjusted R2 = .23, a change that showed a trend towards significance (F(1,136) 
= 3.10, p = .081). 
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Discussion 
 This study aimed to examine the predictive role of anxiety and depression 
related attitudes and beliefs in treatment outcomes in CBT for depressive and anxiety-
related disorders in the context of routine clinical practice. It was hypothesised that pre-
treatment attitudes and beliefs would significantly predict post-treatment outcomes, 
where greater levels of pre-treatment maladaptive beliefs would be associated with 
poorer outcomes. These hypotheses were not supported as results demonstrated that 
neither pre-treatment depression nor anxiety related attitudes and beliefs significantly 
predicted post-treatment outcomes.  
 Higher initial symptom severity significantly predicted post-treatment 
outcomes, where higher initial symptom severity predicted poorer treatment outcomes, 
except for RCSI in anxiety symptoms where pre-treatment symptom severity did not 
predict RSCI status. Previous studies have shown that higher initial symptom severity 
predicts poorer outcomes in CBT in depression (Carter et al., 2018; Vittengl et al., 
2016), anxiety disorders as a group (Arch & Ayers, 2013), and specific anxiety 
disorders such as panic disorder (Dow et al., 2007a, 2007b), social anxiety disorder 
(Eskildsen et al., 2010) and OCD (Knopp et al., 2013; Kyrios et al., 2015). 
 Cognitive theory highlights an association between symptoms of mental health 
difficulties and cognitive variables, such as maladaptive attitudes and beliefs. This 
study therefore focused on the role of attitudes and beliefs in predicting treatment 
outcomes. The findings that anxiety and depression related attitudes and beliefs did not 
predict outcomes in CBT is in contrast to some of the existing research. For example, 
previous studies have demonstrated that lower levels of pre-treatment depression-
related maladaptive attitudes and beliefs predict improved response to treatment 
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(Jacobs et al., 2009; Sotsky et al., 1991). However, in line with the current study, 
Fournier et al. (2009) did not find a relationship between cognitive dysfunction and 
cognitive therapy outcomes. However, Fournier et al. (2009) looked at cognitive 
dysfunction as a domain comprising of five cognitive variables, of which dysfunctional 
attitudes and beliefs was one. In the current study the sample size for the analysis 
examining depression-related attitudes and beliefs was small and did not reach the 
number required for sufficient statistical power, therefore it is possible that an effect 
was missed due to this.  
 Results from the analyses examining anxiety-related attitudes and beliefs are in 
line with some previous studies, however not others. As previously outlined, the 
existing literature examining the predictive role of attitudes and beliefs in treatment 
outcomes for anxiety disorders is mixed, with some studies highlighting that pre-
treatment attitudes and beliefs do not significantly predict post-treatment outcomes 
(Knopp et al., 2013), others highlighting that they do (Dow et al., 2007b; Meuret et al., 
2010) and others suggesting that particular beliefs may predict post-treatment symptom 
severity (Kyrios et al., 2015; Steketee et al., 2018).  
 This was the first study to use the anxiety attitudes and beliefs scale, which 
examines attitudes and beliefs across the anxiety disorders, in predicting treatment 
outcomes; other studies have examined beliefs related to specific disorders and a range 
of measures have been used to assess attitudes and beliefs. It is possible that this 
heterogeneity in measures used has contributed to the diversity in conclusions drawn 
about the predictive role pre-treatment attitudes and beliefs have in understanding 
differential responses to treatment. 
139 
 
 Cognitive behavioural theories for anxiety disorders place differing emphases 
on the role of cognitions and behaviours in the development and maintenance of anxiety 
disorders and their role in symptom remission in psychological treatments (Powers et 
al., 2017). The results of the current study suggest that anxiety-related attitudes and 
beliefs do not predict outcomes of therapy, potentially indicating that this should not be 
used to guide treatment decisions at this stage and suggesting that people with more 
maladaptive attitudes and beliefs are no less likely to recover. It is possible that other 
factors, such as alternative cognitive variables or behavioural factors, might have a 
significant predictive role in treatment outcomes. However, due to methodological 
limitations of this study and that it was the first study using the AABS-18 to examine 
attitudes and beliefs as predictors of outcome it would be important to replicate these 
findings before further conclusions can be drawn. 
 In the current study, the hypotheses and primary analyses were related to the 
overall level of maladaptive attitudes and beliefs, measured by a total score representing 
the extent to which individuals held specific maladaptive attitudes and beliefs. 
However, it might be that specific, rather than overall level of maladaptive attitudes and 
beliefs are more predictive of treatment outcome and this information may have more 
clinical utility in personalising treatment. This has been found in a small number of 
studies, where it has been demonstrated that in depression perfectionism but not need 
for approval beliefs predict therapeutic outcomes (Blatt et al., 1995), and in OCD that 
pre-treatment perfectionism and intolerance of uncertainty beliefs (Kyrios et al., 2015), 
and responsibility/threat and importance/control of thoughts beliefs (Steketee et al., 
2018) significantly predict therapeutic outcomes. In the current study this was 
examined in post-hoc exploratory analyses, however results were non-significant 
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suggesting that specific attitudes and beliefs, measured by the DAS-SF and AABS-18 
subscales, did not predict post-treatment symptom severity. However, the sample 
examining depression-related attitudes and beliefs was small and underpowered, 
therefore it is possible that with a larger sample size an effect may be detected. The 
body vigilance, anxiety-based reasoning and catastrophising AABS-18 subscales were 
positively correlated with post-treatment GAD symptom severity, where higher levels 
of these attitudes and beliefs were associated with increased post-treatment symptom 
severity. These processes may therefore warrant further investigation, particularly as 
there were some methodological limitations to study, outlined further below. 
 There is increasing evidence for the utility of transdiagnostic and process-
focused cognitive-behavioural treatments for mental health difficulties (Harvey, 
Watkins, Mansell, & Shafran, 2004; McManus, Shafran, & Cooper, 2010). It has been 
suggested that process-focused treatments are more able to focus on improving overall 
wellbeing as opposed to solely the remission of symptoms and that this approach fits 
with the trend towards personalised treatments (Hayes & Hofmann, 2017). Developing 
a more in-depth understanding of particular patterns of beliefs individuals hold and if 
and how this contributes to treatment outcomes could support more process-based 
treatments and is likely to become increasingly important in personalised medicine 
(Hofmann & Hayes, in press). 
 In cognitive therapy the focus is on identifying and modifying maladaptive 
cognitions including negative automatic thoughts, attitudes and beliefs (Hawton, 
Salkovskis, Kirk, & Clark, 1989), therefore it is possible that change in beliefs might 
be more important in predicting treatment outcomes than pre-treatment belief level. For 
example, Kyrios et al. (2015) found that initial OCD-related beliefs did not predict 
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recovery status but demonstrated that changes in OCD-related beliefs over treatment 
were significantly correlated with change in symptom severity. Furthermore, Lorenzo-
Luaces et al. (2015) suggest in a recent review that empirical research indicates that 
cognitive change over therapy contributes to symptom change in cognitive therapy for 
depression. It may therefore be important for future research to examine change in 
beliefs over the course of treatment and the contribution this has to treatment outcomes. 
However, this taps into mediators of therapeutic change, rather than factors that can be 
used to predict outcomes, inform formulations and treatment assignment, for example. 
 Participants in the current sample had a range of diagnoses and therefore 
symptom presentations, see Table 1. It is therefore possible that the measures used to 
examine outcomes did not capture the specific symptoms an individual presented with 
and were therefore not representative of treatment outcomes or processes that changed 
during therapy. This may have contributed to the lack of predictive value of attitudes 
and beliefs in treatment outcomes as the outcomes that changed may not have been 
accurately measured.  
Limitations. 
 One of the primary limitations of this study was sample size in the sample 
examining depression-related attitudes and beliefs. Data from 51 participants was 
collected for these analyses, however the power calculation indicated that 117 
participants would be required. These analyses were therefore not sufficiently powered 
to detect an effect, increasing the probability that a Type II error occurred and an effect 
was missed. 
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 During recruitment the research questionnaires were not given to everyone 
eligible to participate. This increased the risk of sampling bias meaning that the sample 
may not have been representative of the target population. Over the previous year, the 
percentage of females having an assessment or receiving therapy within Service 1 was 
65%, which is in contrast to the 74% who participated in this study, Table 1. 
Furthermore, the population of white British clients in Service 1 who participated in 
this study was 65%, whereas this figure was 35% for the whole service, indicating that 
the sample in this study was not representative of the service. Demographic data for the 
service was not available for Service 2. 
 Due to the time scale in needing to complete data collection for this project, all 
participants had not completed therapy and PHQ-9 and GAD-7 data were collected 
from their latest, rather than final, therapy session. It is possible this led to a bias in 
results; for example, participants may have shown a greater improvement in outcomes 
had they completed therapy.  
 Although the GAD-7 questionnaire is reported to be a valid and reliable 
screening tool for various anxiety disorders (Kroenke et al., 2007), it specifically 
measures symptoms of GAD. The diagnoses in the current sample were diverse (see 
Table 1), therefore it is possible that the GAD-7 questionnaire did not accurately 
represent anxiety symptoms individuals presented with. Using data from disorder 
specific outcome measures may therefore have been preferable, however these are not 
regularly collected in services.  
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Recommendations for future research. 
 This study reviewed outcomes related to depression and anxiety symptom 
severity. Looking at treatment outcomes related to disorder specific measures could be 
important to ensure that the outcomes being measured are those that are being treated 
in therapy. However, Powers et al. (2017) suggest that the focus on reducing symptoms 
as a primary outcome in CBT is shifting to a focus on looking at functional outcomes 
or changes in values-guided behaviour as therapeutic outcomes, regardless of symptom 
severity. Future research could therefore review outcomes that are less symptom 
focused and are more focused on functional outcomes such as quality of life or 
wellbeing, or those related to values-guided or goal-directed behaviour. Future research 
could also focus on specific attitudes and beliefs, rather than overall level of 
maladaptive attitudes and beliefs.  
 In consultation with a service user group, it was suggested that future research 
could take a qualitative focus to form a data driven approach to examining which factors 
participants understand to be most important in predicting therapeutic outcomes. An 
interview schedule such as the Elliot change interview (Elliott, 1999) could be used for 
this purpose.  
 A further method of understanding predictors of therapeutic outcome could be 
to relate pre-treatment attitudes and beliefs to different trajectories of change over 
therapy such as sudden gains, early response, late response, gradual improvement and 
gradual decline.  
Due to challenges with data collection it was not possible to give participants 
the DAS-SF and AABS-18 at time points beyond the assessment session in the current 
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study. It was therefore not possible to look at change in attitudes and beliefs over the 
course of therapy and whether this change predicts therapeutic outcomes. As previously 
outlined, change in attitudes and beliefs may have more influence on treatment 
outcomes than pre-treatment symptom levels, and potentially increased clinical utility 
in understanding the importance of modifying attitudes and beliefs during therapy. 
 This study only reviewed clinically significant, reliable, and reliable and 
clinically significant improvement. There is increasing evidence for possible negative 
effects of psychological therapy (Crawford et al., 2016), therefore in future research it 
may also be important to examine the impact of predictors of outcome on deterioration 
in therapy.  
Conclusion. 
 This study examined the role of pre-treatment attitudes and beliefs in predicting 
outcomes following CBT. It was shown that pre-treatment symptom severity 
significantly predicted treatment outcomes, but attitudes and beliefs did not. This is a 
complex area with potential predictors falling into various categories including 
demographic, symptom/disorder, cognitive, motivational, biological or social and 
outcomes are likely to depend on a combination of these factors. Currently, the 
treatment outcome prediction literature presents mixed findings about factors that 
predict outcomes in therapy. There is an ongoing need to develop understanding of 
factors that identify people at risk of poorer therapeutic outcomes to be able to support 
personalising treatment, appropriate treatment assignment, formulation and the 
development of therapies with increased efficacy. It will be important for future 
research to consider the existing literature base to address current methodological 
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limitations and refine the factors that contribute to improved or poorer treatment 
outcomes. 
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Integration, Impact and Dissemination 
Integration 
The overall aim of this project was to develop an understanding of and review 
potential predictors of outcome and mechanisms of change in cognitive behavioural 
therapies for depression and anxiety disorders.  
There are a number of cognitive-behavioural theories and models to understand 
different psychiatric disorders (e.g., Beck, 1963, 1964; Clark, 1996; Clark & Wells, 
1995; Ehlers & Clark, 2000; Salkovskis, 1996). These have informed our understanding 
of the onset and maintenance of these disorders and an established body of empirical 
research supports these theoretical frameworks. Cognitive-behavioural theories and 
models have led to the development of a range of treatments for various psychiatric 
diagnoses, which have well-established empirical support for their efficacy (Carpenter 
et al., 2018; Hofmann, Asnaani, Vonk, Sawyer, & Fang, 2012). However, factors that 
predict response to therapy, particularly theorised processes such as cognitive variables, 
and potential mechanisms through which interventions work have received relatively 
less attention in the literature to date (Holmes et al., 2018). Research into this area aims 
to develop our understanding of the reasons why treatment is more effective for some 
but not others, the processes that change during therapy and how change in these 
processes contributes to different outcomes. This has the potential to guide individual 
formulation, enhance personalised medicine to improve precision in matching 
treatments to individuals, inform pathways within clinical services and allocation of 
resources, and inform treatment development to directly target the processes 
responsible for change, which could enhance the efficacy and efficiency of treatments 
(Holmes et al., 2018). 
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Research into personalised medicine, factors that predict treatment outcomes, 
and mechanisms of psychological treatments has been gaining increased attention over 
recent years. For example, a recent commission by the Lancet Psychiatry made ten 
recommendations for priorities in advancing psychological treatment research, of 
which understanding how existing treatments work, the mechanisms of psychological 
treatments, “who should be treated, for what and with what”, and personalised treatment 
approaches formed two of the recommendations (Holmes et al., 2018). In addition, the 
mental health research charity ‘MQ’ have highlighted research priorities in 
understanding predictors of treatment outcome, personalised medicine and 
understanding how psychological treatments work, and this area of research forms a 
part of their key research programmes (MQ, 2018).  
This project aimed to contribute to this growing field of research and take a 
specific focus on cognitive-behavioural therapies.  
There are several categories potential mechanisms of therapy might fall into 
including psychological, therapeutic, biological and neuropsychological, therapist, 
demographic, disorder specific and social factors. To establish a focus for the 
systematic review, it was decided that this would concentrate on psychological 
mechanisms. Kazdin (2007) highlighted that a first step in understanding mechanisms 
of psychological treatments is to identify mediators. With this in mind, the systematic 
review focused on psychological mediators in cognitive behavioural therapies. Since 
there have been recent reviews in this area for depression (Lemmens, Müller, Arntz, & 
Huibers, 2016; Lorenzo-Luaces, German, & DeRubeis, 2015) it was determined that 
the review should focus on an anxiety disorder, and generalised anxiety disorder (GAD) 
was selected. This was designed to tie in with the empirical study, which was taking 
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place in an Improving Access to Psychological Therapies (IAPT) service and reviewing 
GAD and depression symptoms as the primary outcomes. In addition, there were no 
published systematic reviews on mediators of outcome in cognitive-behavioural 
therapies for GAD.  
The empirical study examined predictors of outcome in cognitive behavioural 
therapy (CBT) for depression and anxiety disorders, so in this sense had a broader remit 
than the systematic review through including a range of diagnoses. However, the 
empirical study narrowed the mechanism category further to focus on cognitive factors 
(specifically attitudes and beliefs), rather than taking a broader focus on psychological 
factors, as in the systematic review. 
It was initially planned that the empirical study would examine cognitive 
mediators in CBT for depressive and anxiety disorders, rather than cognitive predictors 
of outcome, therefore both the empirical study and systematic review would have 
focused on mediators of change over the course of therapy. This was planned to have 
the benefit of the empirical study following from the systematic review both 
conceptually and methodologically. The systematic review highlighted three key 
methodological limitations to previous studies; that the temporal relationship between 
mediator and outcome variables was not examined in the majority of studies, that 
studies did not experimentally manipulate the proposed mediator, and studies were not 
adequately powered. It was hoped that the empirical study would be able to address two 
of these limitations through examining the temporal relationship between mediator and 
outcome variables and through having a sufficient sample size by collecting data from 
routine clinical practice in an IAPT service. 
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It was planned and agreed with the recruitment site that the measures of attitudes 
and beliefs, the Dysfunctional Attitudes Scale-Short Form (DAS-SF) and Anxiety 
Attitudes and Beliefs Scale-18 (AABS-18) would be introduced into the service as 
routinely collected outcome measures, alongside those already collected in IAPT 
services. This meant that they would be given to all people attending the service for 
assessment and therapy at every second session. This would address the methodological 
limitations of previous studies, where the temporal relationship between mediator and 
outcome variables has not been examined, through collecting mediator and outcome 
variable data at multiple time points throughout therapy (Kazdin, 2007). The service in 
which recruitment was taking place saw a total of 2,873 people for therapy in the 2015-
2016 year and the required sample size for this study was 200, therefore it was agreed 
that this would be an achievable target given that the questionnaires were planned to be 
given routinely to all those attending the service for assessment and therapy.  
However, recruitment was one of the most significant challenges in carrying out 
this project, the specifics of which are discussed further below. Due to the recruitment 
challenges, this made it necessary to modify the design of the study as what had 
previously been understood to be realistic goals were deemed to no longer be 
achievable. It was observed that it was no longer possible for the service to give 
questionnaires to clients during therapy and that we could not reach the recruitment 
target in the time available. The design was therefore changed to examine the predictive 
role of attitudes and beliefs in CBT outcomes, rather than examining their mediational 
role over the course of treatment. Following a literature search it was established that 
predictors of therapeutic outcome examined in the literature had predominantly focused 
on factors such as symptom specific or demographic variables, with less research on 
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processes outlined in cognitive-behavioural models (Crits-Christoph, Connolly 
Gibbons, & Mukherjee, 2013; Knopp, Knowles, Bee, Lovell, & Bower, 2013). There 
were some studies in the depression literature, but fewer in the anxiety literature, often 
with mixed findings.  
The consequence of this modification in design was that the whole project did 
not focus on mediators of change and the methodological limitations outlined in the 
systematic review could not be addressed in the empirical study. However, the 
empirical article was able to examine attitudes and beliefs as predictors of therapeutic 
outcome which aimed to contribute to the growing evidence base around personalised 
medicine. This had not yet been examined in a pragmatic context of routine clinical 
practice in the UK. It also enabled key learning around why the methodological 
limitations of previous studies are as they are and possible ways in which to address 
these limitations.  
Recruitment. 
As previously outlined, during recruitment it became clear that the recruitment 
target was not going to be reached in the time available. It was initially determined with 
the service manager and clinical lead that it would be possible for therapists to give the 
research questionnaires to clients, alongside routinely collected IAPT measures. I spent 
one day a week in the service to attend the team meeting, answer questions about the 
study and support the team in giving out questionnaires. Due to confidentiality 
limitations I was unable to identify clients attending for an assessment but was able to 
support this administratively and to speak to and remind clinicians. Following feedback 
from therapists and reviewing recruitment figures it became clear that it was not 
possible for therapists to continue giving out the questionnaires routinely. Alongside 
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the clinical lead, service manager and admin manager it was decided that questionnaires 
and an information sheet would be sent to clients with their initial appointment letter. 
Therapists would therefore only be required to collect the pre-completed questionnaires 
from clients, go through the information sheet and obtain consent. If clients consented 
to their data being shared for research purposes the questionnaires would be handed to 
the research team, otherwise they would be used clinically and in routine outcome 
monitoring for the service. However, only a limited number of questionnaires were 
returned through this process.  
Alongside therapists, the service manager, clinical lead, admin manager and a 
service user involvement group it was determined that an appropriate method of 
distributing questionnaires would be for the administration team the give questionnaires 
to clients attending for an assessment when they arrived for their appointment. Clients 
would complete the questionnaires in the waiting room then return them to therapists 
in their session. At this point, therapists would go through an information sheet and ask 
for consent to share data for research purposes. 
Ideally, I would have identified clients attending for an assessment appointment 
and prepared a list for reception staff and questionnaires for each client to support the 
administrative process, however this was not permitted under ethical approval. In 
consultation with a service user involvement group, two people stated that it would not 
be acceptable to them for the research team to access data prior to consent, one person 
stated this would be acceptable to them and two were more ambivalent, although were 
inclined to think this would be acceptable given the specific circumstances under which 
this would occur. Accessing data prior to consent required an additional application to 
the Confidentiality Advisory Group (CAG). This application was completed however 
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was not processed in sufficient time for data collection for this study. For future 
research it would be beneficial for this application to be submitted at the time of ethical 
approval. 
Due to the increased burden on the administrative team by giving out 
questionnaires at assessment it was agreed that this would be completed for a limited 
period of one-month. There were approximately 30 high intensity assessments 
completed per week, however questionnaires were not given to all clients due to various 
factors, including changes in reception staff during the day and the reception area 
becoming busy. During this period feedback was given to therapists regarding the 
patterns of attitudes and beliefs clients presented with. This was given to therapists in 
graph format with a written summary to explain the pattern of results and scores on 
different DAS-SF and AABS-18 subscales to inform their formulations. The aim was 
to ensure the questionnaires were clinically useful for therapists and clients.   
Ethical amendments were made, submitted and approved by the NHS Research 
Ethics Committee, Health Research Authority and Research and Development to reflect 
these changes. 
Reflections. 
 Although recruitment was a challenge and led to the need to change the design 
and hypotheses of the empirical study, I learnt a considerable amount from this process, 
particularly in understanding the application of research in clinical practice. The service 
manager and clinical lead were on board with the project from the beginning and agreed 
to the research questionnaires being integrated into routine outcome monitoring. 
However, it was difficult to translate this into day-to-day practice, as previously 
outlined. Close consultation with therapists, the administration team and the service 
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user group were helpful and for future studies it would be important to involve these 
groups in the initial set-up and design, rather than at the point of implementation or 
later. 
 Even where therapists and administrative staff were interested in and willing to 
support the study this often did not lead to enhanced data collection. IAPT therapists 
are facing increasing pressures with high caseloads (Steel, Macdonald, Schröder, & 
Mellor-Clark, 2015; Westwood, Morison, Allt, & Holmes, 2017) therefore it is difficult 
for staff to have the capacity to include additional work into their practice. Finding ways 
to reduce the burden on therapists was crucial, alongside making the research relevant 
to their clinical practice and being present in the service to support and remind the team.  
 In speaking to a clinician within the team, they suggested that therapists might 
be concerned about scrutiny of their work and recovery rates. Individual therapist 
recovery rates are tracked in the service, however giving questionnaires to a researcher 
might have presented a barrier. It was emphasised that data were anonymised and 
participants were not matched with therapists in data analysis, however in future 
research it would be important to emphasise this from the outset.  
Impact 
 Service level. 
 The main impact at a service level has been in relation to the implementation of 
research into clinical practice and supporting ongoing research in the service. Despite 
the recruitment challenges and problems encountered, different solutions were 
generated and tested which allowed the data collection process to be refined and an 
understanding of what works best within this service to be developed. 
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 A research group of therapists is in the process of being established within the 
service. This aims to enable therapists with an interest in research to be more actively 
involved, including in the design and implementation of studies and possible authorship 
on publications. The impact of this is in relation to professional development of 
therapists and supporting their interests, supporting ongoing research within the service 
and in developing partnerships between clinical services and research institutions. It is 
suggested that treatments developed in research trials may not translate into routine 
clinical practice and that there are often greater variations in outcomes from routine 
practice than in research trials (Lambert, Hansen, & Harmon, 2010; Richards & 
Borglin, 2011). Therefore, conducting research within clinical services may have the 
advantage of developing a more depth understanding of treatment and recovery rates in 
clinical practice but also support services to refine their practice. In the initial stages of 
the development of this project the clinical lead highlighted that the service was looking 
to improve their recovery rates and had hoped that active research in the service would 
support this aim. 
 Through attending some service user group meetings, a research item has been 
introduced onto the agenda for these meetings. In the meetings I attended I found the 
service user group to be willing to talk about research and a number of ideas for future 
studies and their implementation were generated and discussed. Various potential 
benefits have been identified in conducting research alongside service users including 
both personal, such as enhancement of knowledge and experience, and service level 
benefits, such a broadening the service perspective and making services more 
responsive to user needs (Minogue, Boness, Brown, & Girdlestone, 2005; Omeni, 
Barnes, MacDonald, Crawford, & Rose, 2014). Furthermore, recent recommendations 
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for the advancement of psychological treatments research emphasise that patient and 
public involvement has significant potential to improve this research (Holmes et al., 
2018). 
In this study feedback was given to therapists about the pattern of attitudes and 
beliefs their clients presented with. This aimed to increase the clinical utility of these 
questionnaires and support clinicians in formulation and treatment planning. Feedback 
was received from therapists that this had been a helpful process. In addition, an email 
was received by the supervisor of this project from a therapist asking for advice about 
the results of the DAS-SF and AABS-18 and how this could inform the treatment for a 
client they were feeling stuck with. The introduction of these questionnaires into the 
service therefore had a direct impact on the day-to-day clinical practice of therapists 
within the service.   
 Two clinical psychology trainees at Royal Holloway University of London are 
extending this project over the coming year. It is therefore planned that they will support 
the further development of these changes within the service, which I hope will also 
support them in their research.  
Clinical implications. 
 The systematic review highlighted that change in intolerance of uncertainty, 
change in worry and change in somatic anxiety mediate outcomes in CBT for GAD, 
suggesting it is important to consider and work to modify these processes in therapy. 
This may influence how therapy is delivered, however, it is likely that other mediators 
also play a role in treatment outcomes therefore these processes should be assessed in 
line with individual case formulation and not focused on exclusively.  
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 The empirical article found that pre-treatment attitudes and beliefs did not 
significantly predict outcomes in CBT. This indicates that level of maladaptive beliefs 
should not be used to guide treatment decisions at this stage and suggests that people 
with more maladaptive attitudes and beliefs are no less likely to recover. However, 
given the methodological limitations of this study, for example the size of the sample 
examining depression-related attitudes and beliefs, and that it was the first study using 
the AABS-18 to examine the predictive role of attitudes and beliefs in treatment 
outcomes, it would be premature to draw conclusions that directly influence clinical 
practice. It is possible that this study indicated that some theorised processes, attitudes 
and beliefs in this case, measured at pre-treatment do not directly predict therapeutic 
outcomes, however more research is required to establish whether this is the case. This 
research therefore provided a starting point for understanding predictive roles of 
attitudes and beliefs in treatment outcomes.  
 Understanding predictors of outcome and mechanisms underlying therapeutic 
change involves monitoring processes and outcomes beyond symptom severity. 
Currently, routine outcome monitoring in services is typically focused on symptom 
severity, however to enhance understanding of predictors, moderators and mediators of 
treatment outcomes and to utilise evidence around personalised medicine and treatment 
matching it is likely to be important for services to include additional measures in 
routine practice. This might include measures assessing theorised processes important 
for change in therapy, such as intolerance of uncertainty. This research took place in 
the pragmatic context of an IAPT service and introduced the possibility of including 
additional measures within routine data collection, initiating the application of evidence 
into clinical practice.  
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 On a personal level, this research has drawn my attention to the importance of 
understanding what predicts treatment outcomes, the processes responsible for change 
in therapy and how the current literature can inform clinical practice. I’ve understood 
more of the range of factors that can influence differential treatment outcomes which 
has led me to develop my stance in realising the importance of idiosyncratic 
formulations and understanding factors contributing to treatment outcomes, so I can 
hold these in mind and address these during therapy. This has led to some changes in 
my clinical practice and I have noticed changes in the way I formulate with clients, 
monitor outcomes during therapy, reformulate and deliver therapy. I have developed a 
further interest in process-based therapy and how this can be informed by personalised 
medicine approaches and look forward to further developments in the evidence-base in 
this field.  
Future research. 
 The systematic review summarised the literature evaluating psychological 
mediators of change in cognitive-behavioural therapies for GAD and made 
recommendations for future research. It is planned that this review will be submitted 
for publication which, if accepted, would increase the dissemination and possible 
impact of these findings. It is hoped that the recommendations made in this review will 
inform the design and areas of focus of future research. The systematic review 
supported findings from other reviews of mechanisms of change in cognitive 
behavioural therapies that key methodological limitations of current studies are in 
examining the temporal relationship between variables, sample size, and 
experimentally manipulating the proposed mediator (Lemmens et al., 2016; Lorenzo-
Luaces et al., 2015). With different reviews agreeing on and highlighting these 
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limitations this may influence the direction of future research to address these 
limitations.  
There are criticisms in the literature that findings from larger clinical trials have 
limited applicability in routine clinical practice, often due to strict inclusion criteria 
limiting ecological validity (McMain, Newman, Segal, & DeRubeis, 2015). In addition, 
the Medical Research Council highlight that the element of the research-practice cycle 
that is least well performed is the implementation stage (Medical Research Council, 
2000, 2008). Further impact this thesis may have is in informing future research in 
pragmatic contexts and implementation of the evidence base into clinical practice. The 
learning points from this project have been discussed with clinical psychology trainees 
continuing and expanding this project over the coming year, the project supervisor, and 
were discussed with the service during the running of this project. Future meetings will 
also be held with the service user and the therapist research groups to further develop 
the partnership between the clinical service and research team. It is hoped that these 
learning points will influence future research within the pragmatic context of routine 
clinical practice, particularly around the practical and logistical applications.   
Addition reflections. 
 This project has also led me to reflect on the role of clinical psychologists as 
clinicians and researchers and has informed my understanding of the importance of and 
opportunities for research in clinical practice. Throughout clinical psychology training 
and in carrying out this research project I’ve observed and practiced the potential dual 
role of a clinical psychologist both as a clinician and researcher implementing evidence-
based practice, generating practice-based evidence and carrying out more formal 
research. There are often several perceived barriers to research within clinical roles, one 
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I have encountered in my clinical roles being applying for NHS research ethics 
approval, and others being some of the barriers to carrying out research that were 
encountered in this study. This research has given me confidence and knowledge to 
understand and navigate the processes in clinically applied research, which I hope will 
influence my future career, particularly in relation to service development.  
Dissemination 
It is planned that the systematic review will be submitted for publication. It is 
also hoped that the empirical article will be submitted for publication, however it is 
likely that this will focus on outcomes for anxiety-related attitudes and beliefs as the 
analyses for depression-related attitudes and beliefs were underpowered. A potential 
journal that the systematic review and empirical article might be suitable for publication 
in is Behaviour Research and Therapy.  
I plan to attend the service in which data was collected to feedback and present 
the results to the team and discuss them further with the service user involvement group. 
Results were also presented at the Royal Holloway University of London research day.  
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Appendices 
Appendix 1 – Dysfunctional Attitudes Scale – Short Form 1 (DAS-SF; Beevers, 
Strong, Meyer, Pilkonis, & Miller, 2007) 
 
 
 
Note. For the empirical study, the numbers were reversed to be in line with the Anxiety 
Attitudes and Beliefs Scale and in order that higher scores represented more 
maladaptive beliefs. This meant 1 = totally disagree, 2 = disagree, 3 = agree, 4 = totally 
agree. 
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Appendix 2 – Anxiety Attitudes and Beliefs Scale-18 (AABS-18; Brown, Hawkes, 
Cooper, Jonsdottir, & Tata, 2015) 
 
INSTRUCTIONS:  This inventory lists different beliefs that people sometimes hold.  Please 
read each statement carefully, decide how much you believe what is stated, and circle the 
number corresponding to how much you agree.  Please try not to think too much about each 
item--people are different, so there is no right or wrong answer.  To decide how much you agree 
with a statement, simply keep in mind what you are like most of the time using the following 
key:    
    1 = Totally Disagree          2 = Disagree          3 = Agree      4 = Totally Agree 
 
EXAMPLE 
 
You should not put off until tomorrow what you can 
do today. 
 
     1             2         3   4 
 
In the example, the number “3” has been circled indicating agreement but not total agreement. 
 
1. The way to avoid problems is not to take any 
risks. 
    1             2         3   4 
 
2. Even with small problems, one thing can lead to 
another and quickly turn into something huge. 
     1             2         3   4 
 
3. If you imagine something bad happening, it can 
help make that thing come true. 
     1             2         3   4 
 
4. It is better not to rock the boat than to make 
changes. 
     1             2         3   4 
 
5. People will make negative judgments if they think 
something is wrong with you. 
     1             2         3   4 
 
6. Anticipating the worst outcome prepares you for 
the worst. 
     1             2         3   4 
 
7. Planning every detail in advance is the only way 
to avoid unpleasant surprises.   
     1             2         3   4 
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8. It is important to be on the lookout for the first, 
small signs of an illness. 
     1             2         3   4 
 
9. Anxiety is generally a sign that something is 
wrong. 
     1             2         3   4 
 
10. Picturing something happening might cause it to 
really happen. 
     1             2         3   4 
 
11. It is best not to let on if you are in public and feel 
that something is wrong with you. 
     1             2         3   4 
 
12. Minor difficulties can easily get out of control and 
grow into major ones. 
     1             2         3   4 
 
13. There is no such thing as being too careful when it 
comes to your health. 
     1             2         3   4 
 
14. An unusual physical sensation in your body is 
likely to be a sign that something is seriously 
wrong with you.  
     1             2         3   4 
 
15. In general, it is better to keep things the way they 
are than to take the risk of making things worse. 
     1             2         3   4 
 
16. You should not allow yourself to be seen losing 
control of yourself in any way 
     1             2         3   4 
 
17. It is crucial to anticipate potential difficulties so 
that you have a better chance of avoiding them. 
     1             2         3   4 
 
18. If someone is feeling anxious, there must be 
something for them to be concerned about. 
     1             2         3   4 
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Appendix 3 – Patient Health Questionanire-9 (PHQ-9; Kroenke, Spitzer, & 
Williams, 2001) 
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Appendix 4 – Generalised Anxiety Disorder-7 Questionnaire (GAD-7; Spitzer, 
Kroenke, Williams, & Löwe, 2006)  
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Appendix 5 – Participant Information sheet 
 
Mechanisms of change in psychological therapy 
 
Participant Information Sheet 
 
You are being asked to allow information from questionnaires you complete during therapy to 
be used in a research study. This study is being run at [service name] Improving Access to 
Psychological Therapies (IAPT) service and Royal Holloway University of London. 
 
Why have I been invited to take part? 
 
You have been invited to take part as you have attended an assessment appointment or are 
receiving psychological therapy from [service name] IAPT service. 
 
It is known that psychological therapy helps to improve symptoms for a number of different 
mental health difficulties. However, we want to look in more detail at factors that might predict 
outcomes in psychological therapy.  
 
What will I have to do? 
 
During therapy, your therapist will ask you to complete some questionnaires. Everyone who 
has an assessment or receives treatment from an IAPT service is asked to complete 
questionnaires to help understand how they are feeling and to look at changes during therapy.  
 
Information from your questionnaires will be anonymised and this information will then be 
used in the research study.  Other anonymous information will also be used in the research 
such as the number of therapy sessions you attended and basic demographic information.  
 
Do I have to take part? 
 
No, it is completely up to you.  
 
If you do decide to allow your information to be used in this research but later change your 
mind, you are free to withdraw your data from the research, without giving a reason.   
 
Your decision will not affect the healthcare you receive in any way. 
 
Are there any benefits for me? 
 
There are unlikely to be any direct benefits to you from taking part in the study. You are 
currently receiving treatment from an NHS service, and there won’t be any changes to the 
treatment you receive through taking part in this study. We hope that this study will help us to 
understand more about psychological therapy and how it works and be of benefit in the future. 
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Are there any risks for me? 
 
There are no risks involved in taking part in this study as we are using information collected as 
part of routine practice. If you feel uncomfortable or concerned about any of the 
questionnaires, your therapist will be able to talk about this with you and will only continue if 
you are happy to do so. 
 
What will happen to my information? 
 
We will keep all information confidential and protect your privacy at all times. The data used 
for the research will be stored using a unique, anonymous ‘participant number’, so it will not 
include any personal identifying details. This information will be kept for 5 years following 
completion of the study, after which it will be destroyed. One member of the research team, 
who works for the NHS, will have access to NHS records. 
 
Who has approved the study? 
 
All research in the NHS is reviewed by an independent group of people, called a Research Ethics 
Committee, which is there to protect your safety, wellbeing, rights and dignity. This project has 
been reviewed and was given a favourable review by the South Central – Berkshire B Research 
Ethics Committee on 24th April 2017. 
 
What happens next? 
 
If you are willing for your data to be used for this research study, please let your therapist know. 
 
Further information and contact details 
 
If you would like any further information please contact Dorothy King on 
dorothy.king1@nhs.net.  
 
 
Thank you for taking the time to read this information and for your interest in our research. 
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Appendix 6 – Ethical Approval from NHS REC: Favourable ethical opinion 
(Service 1) 
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Appendix 7 – Health Research Authority (HRA) approval confirmation 
(Service 1) 
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Appendix 8 – Research and Development Approval 
(Service 1) 
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Appendix 9 – Ethical Approval from NHS REC: Favourable ethical opinion 
(Service 2) 
 
 
 
 
207 
 
 
 
 
 
 
 
208 
 
 
 
 
 
 
 
 
209 
 
Appendix 10 – Research and Development Approval 
(Service 2) 
 
 
210 
 
 
